KR20080027396A - 안정한 수성 계면활성제 조성물 - Google Patents
안정한 수성 계면활성제 조성물 Download PDFInfo
- Publication number
- KR20080027396A KR20080027396A KR1020087003835A KR20087003835A KR20080027396A KR 20080027396 A KR20080027396 A KR 20080027396A KR 1020087003835 A KR1020087003835 A KR 1020087003835A KR 20087003835 A KR20087003835 A KR 20087003835A KR 20080027396 A KR20080027396 A KR 20080027396A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- acid
- weight
- combination
- amount
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 259
- 239000004094 surface-active agent Substances 0.000 title claims abstract description 94
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 67
- 239000000463 material Substances 0.000 claims abstract description 53
- 150000001875 compounds Chemical class 0.000 claims abstract description 44
- 229920001577 copolymer Polymers 0.000 claims abstract description 40
- 239000006254 rheological additive Substances 0.000 claims abstract description 28
- 230000006641 stabilisation Effects 0.000 claims abstract description 27
- 238000011105 stabilization Methods 0.000 claims abstract description 27
- 125000002091 cationic group Chemical group 0.000 claims abstract description 25
- 230000002378 acidificating effect Effects 0.000 claims abstract description 18
- 239000000725 suspension Substances 0.000 claims abstract description 17
- 239000000118 hair dye Substances 0.000 claims abstract description 13
- 239000002198 insoluble material Substances 0.000 claims abstract 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 116
- 229920000642 polymer Polymers 0.000 claims description 65
- 239000000126 substance Substances 0.000 claims description 65
- -1 polydimethylsiloxane Polymers 0.000 claims description 57
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 48
- 239000002253 acid Substances 0.000 claims description 44
- 239000010445 mica Substances 0.000 claims description 43
- 229910052618 mica group Inorganic materials 0.000 claims description 43
- 239000002453 shampoo Substances 0.000 claims description 42
- 239000003795 chemical substances by application Substances 0.000 claims description 41
- 239000000178 monomer Substances 0.000 claims description 39
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 38
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 36
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 36
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 35
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 28
- 125000000217 alkyl group Chemical group 0.000 claims description 26
- 229940008099 dimethicone Drugs 0.000 claims description 26
- 239000000839 emulsion Substances 0.000 claims description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 21
- 239000000194 fatty acid Substances 0.000 claims description 21
- 229930195729 fatty acid Natural products 0.000 claims description 21
- 239000003513 alkali Substances 0.000 claims description 20
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 18
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 18
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 claims description 17
- 239000004408 titanium dioxide Substances 0.000 claims description 17
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 16
- 239000004530 micro-emulsion Substances 0.000 claims description 15
- 230000003472 neutralizing effect Effects 0.000 claims description 15
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 14
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 14
- 229960004889 salicylic acid Drugs 0.000 claims description 14
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 13
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- 239000004907 Macro-emulsion Substances 0.000 claims description 12
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 12
- 239000003945 anionic surfactant Substances 0.000 claims description 12
- 239000003093 cationic surfactant Substances 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002736 nonionic surfactant Substances 0.000 claims description 12
- 229910052727 yttrium Inorganic materials 0.000 claims description 12
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 11
- 229940061720 alpha hydroxy acid Drugs 0.000 claims description 11
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims description 11
- 239000002280 amphoteric surfactant Substances 0.000 claims description 10
- 125000000129 anionic group Chemical group 0.000 claims description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 10
- 229940086555 cyclomethicone Drugs 0.000 claims description 10
- 229940100608 glycol distearate Drugs 0.000 claims description 9
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- RFQSMLBZXQOMKK-UHFFFAOYSA-N [3-[(4,8-diamino-6-bromo-1,5-dioxonaphthalen-2-yl)amino]phenyl]-trimethylazanium;chloride Chemical group [Cl-].C[N+](C)(C)C1=CC=CC(NC=2C(C3=C(N)C=C(Br)C(=O)C3=C(N)C=2)=O)=C1 RFQSMLBZXQOMKK-UHFFFAOYSA-N 0.000 claims description 8
- HSWXSHNPRUMJKI-UHFFFAOYSA-N [8-[(2-methoxyphenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium;chloride Chemical compound [Cl-].COC1=CC=CC=C1N\N=C/1C2=CC([N+](C)(C)C)=CC=C2C=CC\1=O HSWXSHNPRUMJKI-UHFFFAOYSA-N 0.000 claims description 8
- UXEAWNJALIUYRH-UHFFFAOYSA-N [8-[(4-aminophenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium;chloride Chemical group [Cl-].C12=CC([N+](C)(C)C)=CC=C2C=CC(=O)\C1=N/NC1=CC=C(N)C=C1 UXEAWNJALIUYRH-UHFFFAOYSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 8
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 7
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 7
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 7
- CMPPYVDBIJWGCB-UHFFFAOYSA-N [8-[(4-amino-3-nitrophenyl)hydrazinylidene]-7-oxonaphthalen-2-yl]-trimethylazanium;chloride Chemical compound [Cl-].C12=CC([N+](C)(C)C)=CC=C2C=CC(=O)\C1=N\NC1=CC=C(N)C([N+]([O-])=O)=C1 CMPPYVDBIJWGCB-UHFFFAOYSA-N 0.000 claims description 7
- 229940073609 bismuth oxychloride Drugs 0.000 claims description 7
- 239000001530 fumaric acid Substances 0.000 claims description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 7
- 239000011976 maleic acid Substances 0.000 claims description 7
- 239000007769 metal material Substances 0.000 claims description 7
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 7
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 claims description 7
- 229920000728 polyester Polymers 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims description 6
- 101150065749 Churc1 gene Proteins 0.000 claims description 6
- 208000001840 Dandruff Diseases 0.000 claims description 6
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 6
- CNCOEDDPFOAUMB-UHFFFAOYSA-N N-Methylolacrylamide Chemical compound OCNC(=O)C=C CNCOEDDPFOAUMB-UHFFFAOYSA-N 0.000 claims description 6
- 102100038239 Protein Churchill Human genes 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 claims description 6
- 150000001277 beta hydroxy acids Chemical class 0.000 claims description 6
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 claims description 6
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 6
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 claims description 6
- NWKBFCIAPOSTKG-UHFFFAOYSA-M trimethyl-[3-[(3-methyl-5-oxo-1-phenyl-4h-pyrazol-4-yl)diazenyl]phenyl]azanium;chloride Chemical compound [Cl-].CC1=NN(C=2C=CC=CC=2)C(=O)C1N=NC1=CC=CC([N+](C)(C)C)=C1 NWKBFCIAPOSTKG-UHFFFAOYSA-M 0.000 claims description 6
- 239000000987 azo dye Substances 0.000 claims description 5
- 150000002191 fatty alcohols Chemical class 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 239000001027 temporary hair color Substances 0.000 claims description 5
- 229940043810 zinc pyrithione Drugs 0.000 claims description 5
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 229940078812 myristyl myristate Drugs 0.000 claims description 4
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 claims description 4
- 229910017604 nitric acid Inorganic materials 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims description 4
- 229920013750 conditioning polymer Polymers 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 claims description 2
- 230000004071 biological effect Effects 0.000 claims description 2
- 230000002363 herbicidal effect Effects 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 10
- 241000251468 Actinopterygii Species 0.000 claims 6
- DRMYLINAGHHBNG-UHFFFAOYSA-N 2-oxo-3h-furan-4-carboxylic acid Chemical compound OC(=O)C1=COC(=O)C1 DRMYLINAGHHBNG-UHFFFAOYSA-N 0.000 claims 5
- 229940057874 phenyl trimethicone Drugs 0.000 claims 5
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 4
- 239000001000 anthraquinone dye Substances 0.000 claims 4
- 229910052698 phosphorus Inorganic materials 0.000 claims 4
- 239000011574 phosphorus Substances 0.000 claims 4
- 229910000831 Steel Inorganic materials 0.000 claims 3
- 229940105132 myristate Drugs 0.000 claims 3
- 239000010959 steel Substances 0.000 claims 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 3
- 229920002907 Guar gum Polymers 0.000 claims 1
- 229920006317 cationic polymer Polymers 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 125000005375 organosiloxane group Chemical group 0.000 claims 1
- 230000000361 pesticidal effect Effects 0.000 claims 1
- 238000010348 incorporation Methods 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000003116 impacting effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 description 76
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 52
- 239000008367 deionised water Substances 0.000 description 29
- 229910021641 deionized water Inorganic materials 0.000 description 29
- 239000000047 product Substances 0.000 description 29
- 230000003750 conditioning effect Effects 0.000 description 26
- 229920006037 cross link polymer Polymers 0.000 description 25
- 239000011324 bead Substances 0.000 description 22
- 239000003085 diluting agent Substances 0.000 description 21
- 239000004615 ingredient Substances 0.000 description 20
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 20
- 239000007788 liquid Substances 0.000 description 19
- 239000003002 pH adjusting agent Substances 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 239000003607 modifier Substances 0.000 description 18
- 230000015227 regulation of liquid surface tension Effects 0.000 description 17
- 238000013112 stability test Methods 0.000 description 16
- 239000003623 enhancer Substances 0.000 description 15
- 239000000499 gel Substances 0.000 description 15
- 239000000975 dye Substances 0.000 description 14
- 239000003974 emollient agent Substances 0.000 description 13
- 239000006210 lotion Substances 0.000 description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
- 239000006071 cream Substances 0.000 description 11
- 239000003205 fragrance Substances 0.000 description 11
- 239000003755 preservative agent Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 229910052708 sodium Inorganic materials 0.000 description 11
- 229940083542 sodium Drugs 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 10
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 10
- 229960002216 methylparaben Drugs 0.000 description 10
- 239000003599 detergent Substances 0.000 description 9
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 8
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 8
- 230000001815 facial effect Effects 0.000 description 8
- 230000002335 preservative effect Effects 0.000 description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 7
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 7
- 239000006260 foam Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000002480 mineral oil Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 230000000774 hypoallergenic effect Effects 0.000 description 6
- 235000010446 mineral oil Nutrition 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 229940057950 sodium laureth sulfate Drugs 0.000 description 6
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 230000008719 thickening Effects 0.000 description 6
- 229960004418 trolamine Drugs 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 244000044822 Simmondsia californica Species 0.000 description 5
- 235000004433 Simmondsia californica Nutrition 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 5
- 229960001083 diazolidinylurea Drugs 0.000 description 5
- 238000004851 dishwashing Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- 229920002554 vinyl polymer Polymers 0.000 description 5
- USZDQUQLJBLEDN-UHFFFAOYSA-N 1-(1-tetradecoxypropan-2-yloxy)propan-2-yl propanoate Chemical compound CCCCCCCCCCCCCCOCC(C)OCC(C)OC(=O)CC USZDQUQLJBLEDN-UHFFFAOYSA-N 0.000 description 4
- JNAUPAUCKRVHQD-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;propyl 4-hydroxybenzoate Chemical compound CCCOC(=O)C1=CC=C(O)C=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O JNAUPAUCKRVHQD-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 244000004005 Nypa fruticans Species 0.000 description 4
- 235000005305 Nypa fruticans Nutrition 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 229940067596 butylparaben Drugs 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960003415 propylparaben Drugs 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 239000004753 textile Substances 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 3
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 241000723346 Cinnamomum camphora Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 235000019486 Sunflower oil Nutrition 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 150000003973 alkyl amines Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 229930008380 camphor Natural products 0.000 description 3
- 229940081733 cetearyl alcohol Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000011260 co-administration Methods 0.000 description 3
- 229960004091 diflucortolone Drugs 0.000 description 3
- OGPWIDANBSLJPC-RFPWEZLHSA-N diflucortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O OGPWIDANBSLJPC-RFPWEZLHSA-N 0.000 description 3
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 3
- 238000007720 emulsion polymerization reaction Methods 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229940068977 polysorbate 20 Drugs 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012430 stability testing Methods 0.000 description 3
- 239000002600 sunflower oil Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000004711 α-olefin Substances 0.000 description 3
- OMDMTHRBGUBUCO-IUCAKERBSA-N (1s,5s)-5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol Chemical compound CC1=CC[C@H](C(C)(C)O)C[C@@H]1O OMDMTHRBGUBUCO-IUCAKERBSA-N 0.000 description 2
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 2
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 229920002884 Laureth 4 Polymers 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- HUCJFAOMUPXHDK-UHFFFAOYSA-N Xylometazoline Chemical compound CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCCN1 HUCJFAOMUPXHDK-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 229940091181 aconitic acid Drugs 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000981 basic dye Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229940073669 ceteareth 20 Drugs 0.000 description 2
- 229940056318 ceteth-20 Drugs 0.000 description 2
- 229960002788 cetrimonium chloride Drugs 0.000 description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 2
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 2
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 2
- 229960002626 clarithromycin Drugs 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 229960004703 clobetasol propionate Drugs 0.000 description 2
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 2
- 229960003338 crotamiton Drugs 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 description 2
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 229960002146 guaifenesin Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000010903 husk Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940048866 lauramine oxide Drugs 0.000 description 2
- 229940061515 laureth-4 Drugs 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 2
- 229960004963 mesalazine Drugs 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 229960001238 methylnicotinate Drugs 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- RCAVMXODXXMCER-ASTDGNLGSA-N n,n-dimethyl-2-[2-[(e)-2-pyridin-2-ylethenyl]phenoxy]ethanamine;hydrochloride Chemical group Cl.CN(C)CCOC1=CC=CC=C1\C=C\C1=CC=CC=N1 RCAVMXODXXMCER-ASTDGNLGSA-N 0.000 description 2
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- SRQKTCXJCCHINN-NYYWCZLTSA-N nifuratel Chemical compound O=C1OC(CSC)CN1\N=C\C1=CC=C([N+]([O-])=O)O1 SRQKTCXJCCHINN-NYYWCZLTSA-N 0.000 description 2
- 229960002136 nifuratel Drugs 0.000 description 2
- 229960000564 nitrofurantoin Drugs 0.000 description 2
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229940100460 peg-100 stearate Drugs 0.000 description 2
- 229940043138 pentosan polysulfate Drugs 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 2
- 229960000395 phenylpropanolamine Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 description 2
- 229960001807 prilocaine Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 2
- MFBSLPHMAVHSHH-UHFFFAOYSA-M sodium;propyl 4-hydroxybenzoate;hydroxide Chemical compound [OH-].[Na+].CCCOC(=O)C1=CC=C(O)C=C1 MFBSLPHMAVHSHH-UHFFFAOYSA-M 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 229940105956 tea-dodecylbenzenesulfonate Drugs 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 1
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
- PDHSAQOQVUXZGQ-JKSUJKDBSA-N (2r,3s)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2h-chromene-5,7-diol Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2OC)=CC=C(O)C(O)=C1 PDHSAQOQVUXZGQ-JKSUJKDBSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
- JXYWFNAQESKDNC-BTJKTKAUSA-N (z)-4-hydroxy-4-oxobut-2-enoate;2-[(4-methoxyphenyl)methyl-pyridin-2-ylamino]ethyl-dimethylazanium Chemical compound OC(=O)\C=C/C(O)=O.C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 JXYWFNAQESKDNC-BTJKTKAUSA-N 0.000 description 1
- GJHKWLSRHNWTAN-UHFFFAOYSA-N 1-ethoxy-4-(4-pentylcyclohexyl)benzene Chemical compound C1CC(CCCCC)CCC1C1=CC=C(OCC)C=C1 GJHKWLSRHNWTAN-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- OUNZARDETXBPIX-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)acetic acid Chemical compound CCCCCCCCCCCCOCCOCC(O)=O OUNZARDETXBPIX-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 1
- XILVEPYQJIOVNB-UHFFFAOYSA-N 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester Chemical compound OCCOCCOC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 XILVEPYQJIOVNB-UHFFFAOYSA-N 0.000 description 1
- BIHQJMSIEXRWPS-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;dodecyl dihydrogen phosphate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOP(O)(O)=O BIHQJMSIEXRWPS-UHFFFAOYSA-N 0.000 description 1
- HYZPVMPQJVVJBP-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;propane-1,2,3-triol Chemical compound OCC(O)CO.OCCN(CCO)CCO HYZPVMPQJVVJBP-UHFFFAOYSA-N 0.000 description 1
- CDVMRBKZDAJYGH-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;propane-1,2-diol Chemical compound CC(O)CO.OCCN(CCO)CCO CDVMRBKZDAJYGH-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- XCHHJFVNQPPLJK-UHFFFAOYSA-N 2-carboxyphenolate;1h-imidazol-1-ium Chemical compound C1=CNC=N1.OC(=O)C1=CC=CC=C1O XCHHJFVNQPPLJK-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- MMDUJZZONSLMRD-UHFFFAOYSA-N 2-hydroxybenzoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)C1=CC=CC=C1O MMDUJZZONSLMRD-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- ZAWQXWZJKKICSZ-UHFFFAOYSA-N 3,3-dimethyl-2-methylidenebutanamide Chemical compound CC(C)(C)C(=C)C(N)=O ZAWQXWZJKKICSZ-UHFFFAOYSA-N 0.000 description 1
- AYKYXWQEBUNJCN-UHFFFAOYSA-N 3-methylfuran-2,5-dione Chemical compound CC1=CC(=O)OC1=O AYKYXWQEBUNJCN-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- FFDVZARSBRNLFY-UHFFFAOYSA-N 4,5-dihydro-3h-pyrazol-3-ylurea Chemical compound NC(=O)NC1CCN=N1 FFDVZARSBRNLFY-UHFFFAOYSA-N 0.000 description 1
- HQARDVLSJLCFBA-UHFFFAOYSA-N 4-[(4-aminophenyl)carbamoyl]-1h-imidazole-5-carboxylic acid Chemical compound C1=CC(N)=CC=C1NC(=O)C1=C(C(O)=O)NC=N1 HQARDVLSJLCFBA-UHFFFAOYSA-N 0.000 description 1
- HWGAOXKGTHUMFZ-UHFFFAOYSA-N 4-butyl-1,2-diphenylpyrazolidine-3,5-dione;piperazine Chemical compound C1CNCCN1.O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 HWGAOXKGTHUMFZ-UHFFFAOYSA-N 0.000 description 1
- AEUAEICGCMSYCQ-UHFFFAOYSA-N 4-n-(7-chloroquinolin-1-ium-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;dihydrogen phosphate Chemical compound OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 AEUAEICGCMSYCQ-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000003901 Crambe Nutrition 0.000 description 1
- 241000220246 Crambe <angiosperm> Species 0.000 description 1
- WHPAGCJNPTUGGD-UHFFFAOYSA-N Croconazole Chemical compound ClC1=CC=CC(COC=2C(=CC=CC=2)C(=C)N2C=NC=C2)=C1 WHPAGCJNPTUGGD-UHFFFAOYSA-N 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004908 Emulsion polymer Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- UUOUOERPONYGOS-CLCRDYEYSA-N Fluocinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](F)C2=C1 UUOUOERPONYGOS-CLCRDYEYSA-N 0.000 description 1
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- CLJHABUMMDMAFA-UHFFFAOYSA-N Nylidrin hydrochloride Chemical compound [Cl-].C=1C=C(O)C=CC=1C(O)C(C)[NH2+]C(C)CCC1=CC=CC=C1 CLJHABUMMDMAFA-UHFFFAOYSA-N 0.000 description 1
- BZARQXGRENRAGM-YQALYVIGSA-N OS(O)(=O)=O.CCCCC1C(O)C(C)CCC(O)CCCC(O)CCCC(O)\C(C)=C\C(OC2OC(CO)C(O)C2O)C(O)CC(O)CC(O)CC(O)CC(O)CCCC\C(C)=C\C(C)C(OC1=O)C(C)C(O)CCCN=C(N)N.CCCCC1C(O)C(C)CCC(O)CCCC(O)CCCC(O)\C(C)=C\C(OC2OC(CO)C(O)C2O)C(O)CC(O)CC(O)CC(O)CC(O)CCCC\C(C)=C\C(C)C(OC1=O)C(C)C(O)CCCN=C(N)N Chemical compound OS(O)(=O)=O.CCCCC1C(O)C(C)CCC(O)CCCC(O)CCCC(O)\C(C)=C\C(OC2OC(CO)C(O)C2O)C(O)CC(O)CC(O)CC(O)CC(O)CCCC\C(C)=C\C(C)C(OC1=O)C(C)C(O)CCCN=C(N)N.CCCCC1C(O)C(C)CCC(O)CCCC(O)CCCC(O)\C(C)=C\C(OC2OC(CO)C(O)C2O)C(O)CC(O)CC(O)CC(O)CC(O)CCCC\C(C)=C\C(C)C(OC1=O)C(C)C(O)CCCN=C(N)N BZARQXGRENRAGM-YQALYVIGSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920000148 Polycarbophil calcium Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical class CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229960002669 albendazole Drugs 0.000 description 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- UQNCVOXEVRELFR-UHFFFAOYSA-N aminopropylone Chemical compound O=C1C(NC(=O)C(N(C)C)C)=C(C)N(C)N1C1=CC=CC=C1 UQNCVOXEVRELFR-UHFFFAOYSA-N 0.000 description 1
- 229950002372 aminopropylone Drugs 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 229940047662 ammonium xylenesulfonate Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960002274 atenolol Drugs 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- LPTWEDZIPSKWDG-UHFFFAOYSA-N benzenesulfonic acid;dodecane Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCCCCCCCCCCC LPTWEDZIPSKWDG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 229960001102 betamethasone dipropionate Drugs 0.000 description 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 description 1
- 229960004324 betaxolol Drugs 0.000 description 1
- CHDPSNLJFOQTRK-UHFFFAOYSA-N betaxolol hydrochloride Chemical compound [Cl-].C1=CC(OCC(O)C[NH2+]C(C)C)=CC=C1CCOCC1CC1 CHDPSNLJFOQTRK-UHFFFAOYSA-N 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- ZPOLOEWJWXZUSP-AATRIKPKSA-N bis(prop-2-enyl) (e)-but-2-enedioate Chemical compound C=CCOC(=O)\C=C\C(=O)OCC=C ZPOLOEWJWXZUSP-AATRIKPKSA-N 0.000 description 1
- ZPOLOEWJWXZUSP-WAYWQWQTSA-N bis(prop-2-enyl) (z)-but-2-enedioate Chemical compound C=CCOC(=O)\C=C/C(=O)OCC=C ZPOLOEWJWXZUSP-WAYWQWQTSA-N 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- BUOSLGZEBFSUDD-BGPZCGNYSA-N bis[(1s,3s,4r,5r)-4-methoxycarbonyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2,4-diphenylcyclobutane-1,3-dicarboxylate Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1C(C=2C=CC=CC=2)C(C(=O)O[C@@H]2[C@@H]([C@H]3CC[C@H](N3C)C2)C(=O)OC)C1C1=CC=CC=C1 BUOSLGZEBFSUDD-BGPZCGNYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- FITWXPZPWVWGJP-UHFFFAOYSA-N butane-1,4-diol;sodium Chemical compound [Na].OCCCCO FITWXPZPWVWGJP-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000012986 chain transfer agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960002328 chloroquine phosphate Drugs 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229960002172 chlorquinaldol Drugs 0.000 description 1
- GPTXWRGISTZRIO-UHFFFAOYSA-N chlorquinaldol Chemical compound ClC1=CC(Cl)=C(O)C2=NC(C)=CC=C21 GPTXWRGISTZRIO-UHFFFAOYSA-N 0.000 description 1
- PMGQWSIVQFOFOQ-YKVZVUFRSA-N clemastine fumarate Chemical compound OC(=O)\C=C\C(O)=O.CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PMGQWSIVQFOFOQ-YKVZVUFRSA-N 0.000 description 1
- 229960002291 clindamycin phosphate Drugs 0.000 description 1
- 229960001357 clocortolone pivalate Drugs 0.000 description 1
- SXYZQZLHAIHKKY-GSTUPEFVSA-N clocortolone pivalate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(Cl)[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)COC(=O)C(C)(C)C)[C@@]2(C)C[C@@H]1O SXYZQZLHAIHKKY-GSTUPEFVSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 229940031728 cocamidopropylamine oxide Drugs 0.000 description 1
- 229940117583 cocamine Drugs 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229940079840 cocoyl isethionate Drugs 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 229960002042 croconazole Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 229960002593 desoximetasone Drugs 0.000 description 1
- VWVSBHGCDBMOOT-IIEHVVJPSA-N desoximetasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@@H]2O VWVSBHGCDBMOOT-IIEHVVJPSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- SOYKEARSMXGVTM-HNNXBMFYSA-N dexchlorpheniramine Chemical compound C1([C@H](CCN(C)C)C=2N=CC=CC=2)=CC=C(Cl)C=C1 SOYKEARSMXGVTM-HNNXBMFYSA-N 0.000 description 1
- 229960001882 dexchlorpheniramine Drugs 0.000 description 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940048676 diethylamine salicylate Drugs 0.000 description 1
- 229960004890 diethylpropion Drugs 0.000 description 1
- ICFXZZFWRWNZMA-UHFFFAOYSA-N diethylpropion hydrochloride Chemical compound [Cl-].CC[NH+](CC)C(C)C(=O)C1=CC=CC=C1 ICFXZZFWRWNZMA-UHFFFAOYSA-N 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- VVYDVQWJZWRVPE-UHFFFAOYSA-L dimethyltin(2+);diiodide Chemical compound C[Sn](C)(I)I VVYDVQWJZWRVPE-UHFFFAOYSA-L 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
- 229960001253 domperidone Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- XLMJRFCCCWFQRE-SJRQCXNHSA-N ecboline Chemical compound C([C@H]1[C@]2(O)O3)CCN1C(=O)CN2C(=O)[C@]3(C(C)C)NC(=O)[C@@H](CN(C)[C@@H]1C2)C=C1C1=C3C2=CNC3=CC=C1 XLMJRFCCCWFQRE-SJRQCXNHSA-N 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960001493 etofenamate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960004500 flubendazole Drugs 0.000 description 1
- CPEUVMUXAHMANV-UHFFFAOYSA-N flubendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=C(F)C=C1 CPEUVMUXAHMANV-UHFFFAOYSA-N 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 229960004369 flufenamic acid Drugs 0.000 description 1
- 229940043075 fluocinolone Drugs 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 229960000785 fluocinonide Drugs 0.000 description 1
- GAKMQHDJQHZUTJ-ULHLPKEOSA-N fluocortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O GAKMQHDJQHZUTJ-ULHLPKEOSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- PFEKDNJBEVXNCN-UHFFFAOYSA-N hexadecan-1-ol;octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCC(O)=O PFEKDNJBEVXNCN-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 229960004769 imidazole salicylate Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000001034 iron oxide pigment Substances 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229940100556 laureth-23 Drugs 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Natural products CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- RZKNXPAYKMNEOU-UHFFFAOYSA-N n'-hydroxy-2-nitrobenzenecarboximidamide Chemical compound ON=C(N)C1=CC=CC=C1[N+]([O-])=O RZKNXPAYKMNEOU-UHFFFAOYSA-N 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- HESSGHHCXGBPAJ-UHFFFAOYSA-N n-[3,5,6-trihydroxy-1-oxo-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide Chemical compound CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical compound C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 229960003888 nifuroxazide Drugs 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229940095127 oleth-20 Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 229960004031 omoconazole Drugs 0.000 description 1
- JMFOSJNGKJCTMJ-ZHZULCJRSA-N omoconazole Chemical compound C1=CN=CN1C(/C)=C(C=1C(=CC(Cl)=CC=1)Cl)\OCCOC1=CC=C(Cl)C=C1 JMFOSJNGKJCTMJ-ZHZULCJRSA-N 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- BAINIUMDFURPJM-UHFFFAOYSA-N oxatomide Chemical compound O=C1NC2=CC=CC=C2N1CCCN(CC1)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 BAINIUMDFURPJM-UHFFFAOYSA-N 0.000 description 1
- 229960002698 oxatomide Drugs 0.000 description 1
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000001024 permanent hair color Substances 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960001236 phenylbutazone piperazine Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229960001416 pilocarpine Drugs 0.000 description 1
- RNAICSBVACLLGM-GNAZCLTHSA-N pilocarpine hydrochloride Chemical compound Cl.C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C RNAICSBVACLLGM-GNAZCLTHSA-N 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229950005134 polycarbophil Drugs 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- AZIQALWHRUQPHV-UHFFFAOYSA-N prop-2-eneperoxoic acid Chemical class OOC(=O)C=C AZIQALWHRUQPHV-UHFFFAOYSA-N 0.000 description 1
- MILWSGRFEGYSGM-UHFFFAOYSA-N propane-1,2-diol;propane-1,2,3-triol Chemical compound CC(O)CO.OCC(O)CO MILWSGRFEGYSGM-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229960003908 pseudoephedrine Drugs 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 229940048383 pyrethrum extract Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- XHKUDCCTVQUHJQ-LCYSNFERSA-N quinidine D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 XHKUDCCTVQUHJQ-LCYSNFERSA-N 0.000 description 1
- 229960002454 quinidine gluconate Drugs 0.000 description 1
- 229960004482 quinidine sulfate Drugs 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000012966 redox initiator Substances 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229960001487 rimexolone Drugs 0.000 description 1
- QTTRZHGPGKRAFB-OOKHYKNYSA-N rimexolone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CC)(C)[C@@]1(C)C[C@@H]2O QTTRZHGPGKRAFB-OOKHYKNYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 229960000230 sobrerol Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- 229940084026 sodium valproate Drugs 0.000 description 1
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- OMDMTHRBGUBUCO-UHFFFAOYSA-N trans-sobrerol Natural products CC1=CCC(C(C)(C)O)CC1O OMDMTHRBGUBUCO-UHFFFAOYSA-N 0.000 description 1
- 229940077400 trideceth-12 Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000008340 white lotion Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229960000833 xylometazoline Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3757—(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions
- C11D3/3765—(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions in liquid compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
- A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0089—Pearlescent compositions; Opacifying agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/436—Interference pigments, e.g. Iridescent, Pearlescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머(30%) 나트륨 라우레쓰 술페이트 (2몰, 25%) 수산화나트륨(18%) | qs 4.00 25.0 0 0.75 | 희석제 유동성 개질제 주요 계면활성제 중화제 | (비에프굿리치) 스탠더폴 ES-2 (헨켈) |
파트 B 탈이온수 NaOH (18%) 구아르 히드록시프로필 트리모늄 클로라이드 | 5.00 0.05 0.30 | 희석제 pH 조절제 컨디셔너 | 코스메디아 구아르 C-261N (헨켈) |
파트 C 라우릴 글루코시드(50%) 나트륨 라우릴 술페이트 (29%) 글리콜 디스테아레이트 (및) 라우레쓰-4 (및) 코카미도프로필베타인 | 4.00 15.0 0 3.00 | 보조-계면활성제 보조-계면활성제 광택제 | 플랜타렌 1200엔 (헨켈) 스탠더폴 WAQ-스페셜 (헨켈) 유퍼란 PK-3000(헨켈) |
디메티콘 (및) 라우레쓰-4 (및) 라우레쓰-23 코카미도프로필베타인(35%) 코코-글루코시드 (및) 글리세릴 올레이트 방향제 페녹시에탄올 (및) 메틸파라벤 (및) 부틸파라벤 (및) 에틸파라벤 (및) 프로필파라벤 시트르산 (50%) | 3.00 3.00 1.00 0.50 0.50 0.40 | 컨디셔닝제 거품 보조투여제 수분공급제 미감 증강제 방부제 pH 조절제 | DC 1664 에멀젼 (다우 코닝) 벨베텍스 BA-35 (헨켈) 라메소프트 PO-65 (헨켈) 페노니프 (니파) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 매끄럽고, 광택 및 점성이 있는 액체 5.5 내지 5.8 8,000 내지 10,000 140 내지 160 13.7 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) 나트륨 라우레쓰 술페이트 (3몰, 28%) 수산화나트륨(18%) 코카미도프로필 히드록시술타인 (50%) 이나트륨 라우레쓰 술포숙시네이트 (40%) | qs 5.00 30.00 1.00 10.00 10.00 | 희석제 유동성 개질제 주요 계면활성제 중화제 보조-계면활성제 보조-계면활성제 | (비에프굿리치) 스탠더폴 ES-3 (헨켈) 미라타인 CBS (로디아) 맥카네이트 EL (맥신티레) |
파트 B 탈이온수 광택제: 실시예 2A 구아닌 실시예 2B 글리콜 디스테아레이트 계면활성제 혼합물 실시예 2C 미카 (및) 이산화티타늄 | qs 0.15 3.00 0.20 | 희석제 미감 증강제 미감 증강제 미감 증강제 | 미얼메이드 AA 유퍼란 PK 3000 티미론 MP 115 |
파트 C 디메티콘 방향제 페녹시에탄올 (및) 메틸파라벤 (및) 부틸파라벤 (및) 에틸파라벤 (및) 프로필파라벤 시트르산 (50%) | 3.00 0.50 0.50 0.35 | 컨디셔너 미감 증강제 방부제 pH 조절제 | 다우 코닝 200 플루이드(60,000cS) 페노니프(니파) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 점성의 매그럽고 광택이 있는 액체 5.4 내지 5.7 2A = 3,600 내지 6,000 2B = 5,300 내지 8,200 2C = 3,600 내지 6,000 80 내지 150 17.4 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) 암모늄 라우레쓰 술페이트 (30%) 암모늄 라우레쓰 술페이트 (3몰, 27%) NaOH(18%) 암모늄 크실렌 술포네이트 (40%) PPG-2 히드록시에틸 코코아미드 (100%) 이나트륨 코캄포아세테이트 (50%) | qs 5.00 40.00 20.00 1.40 2.50 4.00 4.00 | 희석제 유동성 개질제 주요 계면활성제 주요 계면활성제 중화제 굴수성 유발물질 거품 보조투여제 저자극성 계면활성제 | (비에프굿리치) 스탠더폴 AM (스테판) 스탠더폴 EA-3 (헨켈) 스테파네이트 AXS (스테판) 프로미디움 CO (모나) 모나테릭 CLV (모나) |
파트 B 탈이온수 실시예 3A 미카 비함유 실시예 3B 미카, 이산화티타늄 및 산화철 | qs 0.20 | 희석제 미감 증강제 | 클로이소네 스파클 골드 #222J (엥글하드) |
파트 C 아모디메티콘 (및) 트리데세쓰-12 (및) 세트리모늄 클로라이드 방향제 페녹시에탄올 (및) 메틸파라벤 (및) 부틸파라벤 (및) 에틸파라벤 (및) 프로필파라벤 시트르산 (50%) | 3.00 0.50 0.50 1.70 | 컨디셔너 미감 증강제 방부제 pH 조절제 | 다우 코닝 2-8194 마이크로에멀젼 페노니프(니파) |
특성 외관 첨가 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 3A = 투명하고 점성이 있는 액체 3B = 점성이 있는 금빛의 광택성 액체 시트르산 첨가전 시트르산 첨가후 6.5 5.0 3,300 7,800 22 180 24.4 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) 알파-올레핀 술포네이트 (40%) 수산화나트륨(18%) 시트르산 (50%) | qs 5.00 15.00 1.00 0.50 | 희석제 유동성 개질제 주요 계면활성제 중화제 pH 조절제 | (비에프굿리치) 바이오터지 AS-40 (스테판) |
파트 B 탈이온수 알파-올레핀 술포네이트 (40%) 글리세린 살리실산(USP) | 15.00 10.00 2.00 2.00 | 희석제 주요 계면활성제 완화제 활성화제 | 바이어터지 AS-40 (스테판) |
파트 C 코카미도프로필베타인 (35%) 실시예 4A: 칼륨 C12 -13 포스페이트 (40%) FD & C 레드 #33 (0.1%) FD & C 옐로 #6(0.1%) 호호바 비드 실시예 4B: 탈이온수 미카 (및) 이산화티타늄 | 10.00 2.00 0.10 0.20 2.00 qs 0.20 | 거품 보조투여제 저자극성 계면활성제 미감 증강제 미감 증강제 미감 증강제 희석제 미감 증강제 | 벨베텍스 BA-35 (헨켈) 모나팩스 MAP 230 (모나) (BFG 힐톤 데이비스) (BFG 힐톤 데이비스) 플로라비드 (플로라테크) 티미론 MP 115(로나) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 4A = 현탁된 비드가 있는 투명하고 점성이 있는 액체 4B = 광택 및 점성이 있는 흰색 액체 3.8 내지 4.0 5,500 내지 10,000 200 내지 350 14.3 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) 코코일 이세티오네이트 (및) 나트륨 라우로암포아세테이트 (및) 나트륨 크실렌 술포네이트 (38%) 나트륨 라우레쓰 술페이트 (2몰. 27%) | 14.45 5.00 45.0 15.00 | 희석제 유동성 개질제 주요 계면활성제 혼합물 주요 계면활성제 | (비에프굿리치) 미라케어 UM-140 (로디아) 로다펙스 ES-2 (로디아) |
파트 B 탈이온수 NaOH (18%) 구아르 히드록시프로필 트리모늄 클로라이드 시트르산 (50%) | 5.00 0.05 0.15 0.05 | 희석제 pH 조절제 컨디셔닝제 pH 조절제 | 재규어 C-14S (로디아) |
파트 C 나트륨 코캄포아세테이트 (37%) 폴리콰터늄-7 디메티코놀 (및) TEA-도데실벤젠술포네이트 | 5.00 2.00 4.00 | 보조-계면활성제 컨디셔너 컨디셔너 | 미라놀 울트라 C37 (로디아) 미라폴 550 (로디아) DC 1784 에멀젼 (다우 코닝) |
파트 D 탈이온수 미카 (및) 이산화티타늄 | 2.50 0.20 | 희석제 미감 증강제 | 플라멘코 새틴 펄 3500 (엥겔하트) |
파트 E 방향제 페녹시에탄올 (및) 메틸파라벤 (및) 부틸파라벤 (및) 에틸파라벤 (및) 프로필파라벤 시트르산 (50%) | 0.50 0.50 0.60 | 미감 증강제 방부제 pH 조절제 | 페노니프 (니파) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 매끄럽고, 광택 및 점성이 있는 액체 6.4 내지 6.8 17,000 내지 22,000 100 내지 150 23.0 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
탈이온수 아크릴레이트 크로스폴리머 (30%) 나트륨 라우레쓰 술페이트 (2몰, 28%) 수산화나트륨(18%) 코카미도프로필베타인(30%) 폴리콰터늄-39 테트라나트륨 EDTA 방향제 폴리소르베이트 20 비타민 E를 함유한 흰색 비드 | qs 8.00 37.30 1.32 2.10 2.10 0.05 0.50 0.50 1.00 | 희석제 유동성 개질제 주요 계면활성제 중화제 거품 보조투여제 컨디셔닝제 킬레이팅제 방향제 가용화제 수분공급제 | (비에프굿리치) 텍사폰 NSO (헨켈) 테고베타인 L (골드슈미트) 메르콰트 3330(칼곤) 트윈-20 리포펄스 (리포 테크놀로지스) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 점성이 있는 투명한 액체 6.3 내지 6.7 4,000 내지 6,000cP 120 내지 220 11.1 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) | 41.85 10.00 | 희석제 유동성 개질제 | (비에프굿리치) |
파트 B 탈이온수(50℃로 가열) 이나트륨 EDTA 부틸렌 글리콜 나트륨 코캄포아세테이트 (37%) 코카미도포르필 베타인 (35%) 폴리콰터늄-39 프로필렌 글리콜 (및) 디아졸리디닐 우레아 (및) 메틸파라벤 (및) 프로필파라벤 수산화나트륨 (18%) | 15.00 0.05 5.00 15.00 3.00 0.80 0.45 0.25 | 희석제 킬레이터 용매 계면활성제 계면활성제 모발 컨디셔너 방부제 중화제 | 미라놀 울트라 C-37 (로디아) 프로테릭 CAB (프로타민) 머콰트 플러스 3330 (칼곤) 저마벤 II(ISP) |
파트 C 탈이온수(50℃로 가열) 베이직 브라운 17/CI 12251 베이직 블루 99/CI 56059 베이직 레드 76/CI 12245 디메티콘 코폴리올 | 10.00 0.25 0.125 0.125 0.20 | 희석제 염료 염료 염료 모발 컨디셔너 | 아리아너 시엔나 브라운 (트리-K/워너 젠킨슨) 아리아너 스틸 블루 (트리-K/워너 젠킨슨) 아리아너 매더 레드 (트리-K/워너 젠킨슨) DC 193 계면활성제 (다우 코닝) |
파트 D 데실 글루코시드 (50%) 탈이온수 미카 (및) 이산화티타늄 | 4.00 3.00 0.20 | 계면활성제 희석제 광택제 | 플랜타렌 2000 (헨켈 코스파) 티미론 MP-149 다이아몬드 클러스터 (로나) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 암갈색의 광택성 점성 액체 6.8 내지 7.4 5,000 내지 7,000 300 내지 400 8.6 45℃에서 3개월 가속화 통과 7회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) 나트륨 라우릴 술페이트 (29%) 나트륨 라우레쓰 술페이트 (2몰, 25%) 수산화나트륨(18%) | qs 5.00 16.00 16.00 0.65 | 희석제 유동성 개질제 주요 계면활성제 주요 계면활성제 중화제 | (비에프굿리치) 스탠더폴 WAQ-LC (헨켈) 스탠더폴 ES-2 (헨켈) |
파트 B 탈이온수 폴리콰터늄-10 DMDM 히단토인 | 10.00 0.25 0.30 | 희석제 모발 컨디셔너 방부제 | 우케어 중합체 JR-400 (아머콜) 글리던트(론자) |
파트 C 코카미도프로필베타인 (35%) 시트르산 (50%) 아연 피리티온 (48%) 디메티코놀 (및) TEA-도데실벤젠술포네이트 FD & C 블루 #1(0.1%) 방향제 염화나트륨 | 4.00 0.75 2.50 3.00 1.00 0.50 0.60 | 거품 보조투여제 pH 조절제 활성화제 컨디셔너 염료 방향제 점도 증강제 | 벨베텍스 BA-35 (헨켈) 아연 오마딘 (아크 케미컬) DC1784 에멀젼 (다우 코닝) (BFG 힐톤 데이비스) |
특성 외관 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 청색의 불투명한 점성이 있는 액체 5.4 내지 5.7 3,500 내지 5,000 120 내지 170 11.5 45℃에서 1개월 가속화 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 아크릴레이트 크로스폴리머 (30%) 나트륨 라우레쓰 술페이트 (3몰, 28%) 수산화나트륨(18%) 프로필렌 글리콜 | 42.03 10.00 30.00 1.90 2.00 | 희석제 유동성 개질제 주요 계면활성제 중화제 제습제 | (비에프굿리치) 스탠더폴 ES-3 (헨켈) |
파트 B 탈이온수 벤조페논-4 이나트륨 EDTA | 5.00 0.02 0.10 | 희석제 UV 흡수제 킬레이팅제 | 우비뉼 MS-40 (BASF) |
파트 C 코카미도프로필베타인 (35%) | 4.00 | 거품 증강제 | 인크로남 30 (크로다) |
파트 D 폴리소르베이트 20 방향제 프로필렌 글리콜, 디아졸리닐 우레아, 메틸파라벤, 프로필파라벤 흰색 비드 w/비타민 E FD & C 블루 #1(0.1%) FD & C 그린 #5(0.5%) | 0.80 0.60 1.00 1.00 0.05 1.50 | 가용화제 방향제 방부제 수분 공급제 염료 염료 | 트윈 20 (ICI) 저마벤 II(서튼) 리포펄스 (리포 테크놀로지스) (BFG 힐톤 데이비스) (BFG 힐톤 데이비스) |
특성 외관 첨가 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) 안정성 | 점성이 있는 투명한 액체 시트르산 첨가전 시트르산 첨가후 6.5 4.5 4,600 5,500 270 440 10.6 45℃에서 3개월 가속화 통과 5회 동결/해동 사이클 통과 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 글리세린 트리에탄올아민(99%) | 51.55 4.80 0.75 | 희석제 제습제 중화제 | |
파트 B 세틸 알콜 글리세릴 스테아레이트 (및) PEG-100 스테아레이트 스테아르산(3X) 이소프로필 팔미테이트 광유 (및) 라놀린 알콜 디메티콘 | 2.85 4.25 1.45 4.25 4.25 1.45 | 불투명화제 유화제 유화제 완화제 완화제 완화제 | 아르락셀 165 (ICI 서팩턴츠) 아머콜 101(아머콜) DC 200 플루이드 (350cS) (다우 코닝) |
파트 C 아크릴레이트 크로스폴리머 (30%) 락트산(45% 용액) 트리에탄올아민 프로필렌 글리콜 (및) 디아졸리디닐 우레아 (및) 메틸파라벤 (및) 프로필파라벤 | 5.00 13.40 5.00 1.00 | 유동성 개질제 활성화제 중화제 방부제 | (비에프 굿리치) 저마벤 II(서튼) |
특성 외관 pH 점도*(cP) 계면활성제 활성(%) 안정성 | 두꺼운 흰색 크림 3.8 내지 4.1 16,000 내지 18,000 5.7 45℃에서 3개월 가속화 통과 3회 동결/해동 사이클 통과 | ||
제조 과정: 1. 파트 A: 글리세린 및 트리에탄올아민을 탈이온수에 첨가한다. 65℃로 가열한다. 2. 파트 B: 각각의 용기를 모두 합치고 용융될 때까지 가열한다. 세게 교반하면서 파트 A에 첨가한다. 혼합하면서 약 40℃로 냉각한다. 3. 혼합하면서 아크릴레이트 크로스폴리머 중에 천천히 첨가한다. 4. 혼합하면서 락트산 용액을 천천히 첨가한다. 5. 트리에탄올아민을 사용하여 pH를 4.0으로 조절한다. 6. 방부제를 첨가한다. |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A(55℃로 가열) 탈이온수 글리세린 | 76.80 2.50 | 희석제 제습제 | |
파트 B(55℃로 가열) PPG-2 미리스틸 에테르 프로피오네이트 세테아릴 옥타노에이트 해바라기유 세틸 알콜 세테아릴 알콜/세테아레쓰-20 | 2.00 3.25 3.00 1.50 3.00 | 완화제 완화제 완화제 유화제 유화제 | 크로다몰 PMP (크로다) 크로다몰 CAP (크로다) 라네테 16NF (헨켈) 에뮬게이드 1000NI (헨켈) |
파트 C 아크릴레이트 크로스폴리머 (30%) 수산화나트륨(18%) (pH 6.5까지) | 5.00 0.95 | 유동성 개질제 중화제 | 비에프 굿리치 |
파트 D(40℃에서 첨가) 시클로메티콘 (및) 디메티콘 | 1.00 | 윤활제 | DC 1401 플루이드 (다우 코닝) |
파트 E 프로필렌 글리콜 (및) 디아졸리디닐 우레아 (및) 메틸파라벤 (및) 프로필파라벤 | 1.00 | 방부제 | 저마벤 II-E (서튼) |
특성 외관 pH 점도*(cP) 계면활성제 활성(%) | 흰색의 점성이 있는 에멀젼 6.0 내지 7.0 10,000 내지 20,000 4.5 |
성분 | 중량% | 기능 | 제품명 (공급원) |
파트 A 탈이온수 글리세린 | 76.80 2.50 | 희석제 제습제 | |
파트 B 광유 C12 -15 알킬 벤조에이트 옥틸 스테아레이트 세틸 알콜 세테아릴 알콜/세테아레쓰-20 | 4.00 2.50 1.75 1.50 3.00 | 완화제 완화제 완화제 유화제 유화제 | 드라케올 21 (펜레코) 핀솔브 TN(파인텍스) 세티올 868 (헨켈) 라네테 16NF (헨켈) 에뮬게이드 1000NI (헨켈) |
파트 C 아크릴레이트 크로스폴리머 (30%) 수산화나트륨(18%) | 5.00 0.95 | 유동성 개질제 중화제 | (비에프 굿리치) |
파트 D 시클로메티콘 (및) 디메티콘 | 1.00 | 윤활제 | DC 1401 플루이드 (다우 코닝) |
파트 E 프로필렌 글리콜 (및) 디아졸리디닐 우레아 (및) 메틸파라벤 (및) 프로필파라벤 | 1.00 | 방부제 | 저마벤 II-E (서튼) |
특성 외관 pH 점도*(cP) 계면활성제 활성(%) | 흰색 로션 6.0 내지 7.0 15,000 내지 25,000 4.5 |
성분 | 중량% | 기능 | 제품명 (공급원) |
탈이온수 아크릴레이트 크로스폴리머 (30%) d-리모넨 프로필렌 글리콜 글리세린 C12 -15 파레쓰-7 프로필렌 글리콜 (및) 디아졸리디닐 우레아 (및) 메틸파라벤 (및) 프로필파라벤 수산화나트륨(18%) 시트르산 (50%) | qs 4.00 25.00 1.00 2.00 1.00 1.00 1.20 0.25 | 희석제 안정화제 용매 제습제 제습제 계면활성제 방부제 중화제 pH 조절제 | (비에프굿리치) 아릴레센스 네오돌 25-7 (쉘) 저마벤 II-E (서튼 랩스) |
특성 외관 첨가 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) | 불투명하고 점성이 적은 흰색의 분무가능한 로션 시트르산 첨가전 시트르산 첨가후 7.8 6.8 6,500 11,300 520 1,380 1.0 |
성분 | 중량% | 기능 | 제품명 (공급원) |
탈이온수 아크릴레이트 크로스폴리머 (30%) 암모늄 라우릴 술페이트 (28%) 나트륨 라우릴 에테르 술페이트(2몰, 25%) 수산화나트륨(18%) 시트르산 (50%) | qs 5.50 25.00 25.00 1.00 qs | 희석제 유동성 개질제 계면활성제 계면활성제 pH 조절제 pH 조절제 | (비에프굿리치) 스탠더폴 A (헨켈) 스탠더폴 ES-2 (헨켈) |
특성 외관 첨가 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) | 점성이 있는 액체 시트르산 첨가전 시트르산 첨가후 7.0 5.0 1,825 4,550 25 170 13.3 |
성분 | 중량% | 기능 | 제품명 (공급원) |
탈이온수 아크릴레이트 크로스폴리머 (30%) 나트륨 라우릴 에테르 술페이트, 3몰 EO (28%) C12 -13 에톡시화된 선형 알콜, 1몰 EO 수산화나트륨(18%) 시트르산 (50%) | qs 5.00 75.00 2.00 1.00 4.00 | 희석제 유동성 개질제 계면활성제 계면활성제 pH 조절제 pH 조절제 | (비에프굿리치) 스탠더폴 ES-3 (헨켈) 네오돌 23-1 (쉘) |
특성 외관 pH 점도*(cP) 계면활성제 활성(%) | 점성이 있는 액체 3.0 내지 4.0 9000 내지 10,000 21.0 |
성분 | 중량% | 기능 | 제품명 (공급원) |
탈이온수 아크릴레이트 크로스폴리머 (30%) 카보머 나트륨 라우릴 에테르 술페이트, 2몰 EO (25%) 수산화나트륨(18%) 시트르산 (50%) | qs 5.00 0.75 70.00 1.00 4.00 | 희석제 유동성 개질제 유동성 개질제 계면활성제 pH 조절제 pH 조절제 | (비에프굿리치) 카보폴 EZ-1 (비에프굿리치) 스탠더폴 ES-2 (헨켈) |
특성 외관 pH 점도*(cP) 계면활성제 활성(%) | 점성이 있는 액체 4.0 42,000 17.5 |
성분 | 중량% | 기능 | 제품명 (공급원) |
물 아크릴레이트 크로스폴리머 (30%) 알킬벤젠 술폰산 (97%) 나트륨 라우릴 술페이트(29%) 나트륨 라우릴 에테르 술페이트, 2몰 EO (25%) 알킬 폴리글루코시드 (50%) 코코넛 지방산 트리에탄올아민(99%) 글리세린 NaOH(50%) 시트르산 (50%) | qs 7.00 13.50 7.50 7.50 5.00 3.50 7.00 2.00 8.60 8.00 | 희석제 유동성 개질제 계면활성제 계면활성제 계면활성제 계면활성제 계면활성제 pH 조절제 용매 pH 조절제 pH 조절제 | (비에프굿리치) 바이오소프트 S-100 (스테판) 스탠더폴 WAQ (헨켈) 스탠더폴 ES-2(헨켈) 글루코폰 600CS (헨켈) |
특성 외관 시트르산 첨가전 pH 시트르산 첨가후 pH 점도*(cP) 항복값**(dynes/cm2) 계면활성제 활성(%) | 점성이 있는 젤 13.0 8.0 15,000 180 23.2 |
실시예 # | 샘플 A | 샘플 B | 샘플 C | 샘플 D | ||||||||
STAB | SEP | DAY | STAB | SEP | DAY | STAB | SEP | DAY | STAB | SEP | DAY | |
1 | S | 0 | 84 | U | 10 | 14 | U | 2 | 7 | U | 10 | 21 |
2A | S | 0 | 84 | U | 6 | 7 | U | 2 | 21 | U | 6 | 14 |
2B | S | 0 | 84 | U | 10 | 7 | U | 2 | 7 | U | 2 | 91 |
2C | S | 0 | 70 | U | 10 | 7 | U | 4 | 7 | U | 4 | 7 |
3A | S | 0 | 84 | S, LV | 0 | 8 | S | 0 | 77 | U | 2 | 56 |
3B | S | 0 | 84 | U | 10 | 1 | U | 10 | 1 | U | 10 | 14 |
4A | S | 0 | 84 | U | 10 | 1 | U | 10 | 1 | U | 10 | 1 |
4B | S | 0 | 84 | U | 10 | 14 | NT | U | 10 | 7 | ||
5 | S | 0 | 70 | U | 10 | 14 | NT | U | 5 | 21 | ||
6 | S | 0 | 84 | U | 10 | 1 | U | 10 | 7 | U | 5 | 7 |
7 | S | 0 | 84 | NT | NT | U,PR | 14 |
실시예 # | 중합체 | 구분 | pH | 점도* (cP) | 항복값** (dynes/cm2) |
2B | W | 시트르산 첨가전 시트르산 첨가후 | 6.2 5.5 | 1,800 7,400 | 20 160 |
3A | W | 시트르산 첨가전 시트르산 첨가후 | 6.5 5.0 | 3,300 7,800 | 22 180 |
X | 시트르산 첨가전 시트르산 첨가후 | 6.5 5.2 | 11,000 700 | 28 28 | |
9 | W | 시트르산 첨가전 시트르산 첨가후 | 6.5 4.5 | 4,600 5,500 | 270 440 |
X | 시트르산 첨가전 시트르산 첨가후 | 6.5 4.5 | 11,000 700 | 100 25 | |
Y | 시트르산 첨가전 시트르산 첨가후 | 6.5 4.5 | 6,000 2,900 | 300 100 | |
13 | W | 시트르산 첨가전 시트르산 첨가후 | 7.8 6.8 | 6,500 11,300 | 520 1,380 |
14 | W | 시트르산 첨가전 시트르산 첨가후 | 7.0 5.0 | 1,825 4,550 | 25 170 |
실시예 제형에 대한 광택성 외관의 등급 | ||||||||
실시예 # | 초기 등급 | 45℃에서 일주일동안 에이징시킨 후의 등급 | ||||||
중합체 | W | 없음 | X | Y | W | 없음 | X | Y |
2A | 9 | 9 | 9 | 2 | 9 | 1 | 1 | 0 |
2B | 8 | 8 | 8 | 1 | 8 | 0 | 0 | 0 |
2C | 10 | 10 | 10 | 3 | 10 | 0 | 0 | 0 |
3B | 10 | 9 | 9 | 5 | 10 | 0 | 0 | 0 |
4B | 10 | 10 | NT | 6 | 10 | 0 | NT | 0 |
Claims (51)
- a. 하나 이상의 음이온성, 쯔비터 이온성, 양쪽성, 비이온성 또는 양이온성 계면활성제, 또는 이들의 조합물;b. 하나 이상의 실질적으로 가교된 알칼리 팽윤성 아크릴레이트 공중합체 유동성 개질제;c. 물;d. 5 내지 14의 pH를 갖는 조성물을 수득하기 위한 유효량의 하나 이상의 알칼리성 물질; 및e. 1 내지 12의 감소된 pH를 갖는 조성물을 수득하기 위한 후속적으로 첨가되는 유효량의 산성 물질을 포함하는, 안정한 수성 계면활성제 함유 조성물로서,상기 하나 이상의 가교된 알칼리 팽윤성 아크릴레이트 공중합체가,1) 20중량% 내지 80중량%의, 아크릴산, 메타크릴산, 이타콘산, 푸마르산, 크로톤산, 아코니트산 또는 말레산, 또는 이들의 조합물을 포함하는 하나 이상의 카르복실산 단량체;2) 80중량% 내지 15중량%의, 하기 화학식의 단량체로부터 선택되는 하나 이상의 α,β-에틸렌계 불포화 단량체:i) CH2 = CXY,ii) CH2 = CH(OCOR1), 및iii) CH2 = CH2 또는 CH2 = CHCH3(상기 식에서,X는 H이며, Y는 -C6H4R', -CN, -CONH2, -Cl, -NC4H6O, NH(CH2)3COOH, -NHCOCH3, -CONHC(CH3)3, -CO-N(CH3)2 이거나,X는 CH3이며, Y는 -C6H4R', -CN 또는 -CH = CH2 이거나,X는 Cl이며, Y는 Cl이며, R'는 H 또는 C1 -18 알킬이고, R1은 C1 -18 알킬이다); 및3) 0.01중량% 내지 5중량%의, 부분적으로 또는 실질적으로 가교된 3차원 망상구조를 형성하는데 유용한 다중불포화 화합물로부터 중합된 중합체를 포함하는 조성물.
- 제 1항에 있어서, 공중합체의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 10중량%이며, 계면활성제의 양은 안정한 조성물의 전체 중량을 기준으로 하여 1중량% 내지 80중량%인 조성물.
- 제 2항에 있어서, 산성 물질이 시트르산, 아세트산, 베타-히드록시산, 살리실산, 알파-히드록시산, 락트산, 글리콜산, 염산, 황산, 질산, 술팜산, 인산 또는 천연 과일산, 또는 이들의 조합물인 조성물.
- 제 3항에 있어서, 상기 공중합체가,1) 35중량% 내지 65중량%의 아크릴산 또는 메타크릴산, 또는 이들의 조합물,2) 65중량% 내지 35중량%의 에틸아크릴레이트 또는 메틸아크릴레이트, 또는 이들의 조합물; 및3) 0.03중량% 내지 3중량%의, 수크로오스의 폴리알케닐 에테르 또는 폴리알콜; 또는 트리메틸올프로판 트리(메트)아크릴레이트, 글리시딜 메타크릴레이트, N-메틸올아크릴아미드, 또는 이들의 조합물로부터 유도되는 조성물.
- 제 4항에 있어서, 약제학적 활성, 수의학적 활성, 살생적 활성, 제초적 활성, 살충적 활성 또는 다른 생물학적 활성을 갖는, 하나 이상의 생물학적으로 활성인 물질을 포함하는 조성물.
- 제 4항에 있어서, 현탁 또는 안정화가 요구되는 하나 이상의 실질적으로 불용성인 물질을 포함하며, 이러한 실질적으로 불용성인 물질이 실리콘 또는 오일성 물질 또는 광택성 물질, 또는 이들의 조합물인 조성물.
- 제 6항에 있어서, 불용성 실리콘이 폴리디메틸실록산, 아모디메티콘, 아모디메티콘 매크로에멀젼 또는 마이크로에멀젼, 디메티콘, 디메티코놀 (실리콘 검), 시클로메티콘, 페닐트리메티콘, 디메티콘 또는 디메티코놀 마이크로에멀젼 또는 매크 로에멀젼, 유기 폴리실록산, 알콕시실리콘, 또는 이들의 조합물이며, 실리콘의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 20중량%인 조성물.
- 제 6항에 있어서, 불용성의 광택성 물질이 이산화티타늄으로 코팅된 미카, 산화철로 코팅된 미카, 에틸렌글리콜 모노스테아레이트, 에틸렌글리콜 디스테아레이트, 폴리에틸렌 글리콜 디스테아레이트, 비스무트 옥시클로라이드로 코팅된 미카, 미리스틸 미리스테이트, 구아닌 (생선 비늘) 또는 글리터(glitter) (폴리에스테르 또는 금속성 물질), 또는 이들의 조합물이며, 광택성 물질의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.05중량% 내지 10중량%인 조성물.
- 제 7항에 있어서, 조성물이 지방산, 지방산 에스테르, 지방산 알콜, 또는 이들의 조합물을 실질적으로 함유하지 않는 조성물.
- a. 하나 이상의 음이온성, 쯔비터 이온성, 양쪽성, 비이온성 또는 양이온성 계면활성제, 또는 이들의 조합물;b. 하나 이상의 실질적으로 가교된 알칼리 팽윤성 아크릴레이트 공중합체 유동성 개질제;c. 물;d. 불용성 실리콘 또는 불용성 오일 물질, 또는 이들의 조합물인 하나 이상의 화합물; 및e. 최종 pH가 5.0 내지 12가 되도록 하는 유효량의 하나 이상의 중화제를 포함하는, 안정한 수성 계면활성제 함유 조성물에 있어서,상기 하나 이상의 가교된 알칼리 팽윤성 아크릴레이트 공중합체가,1) 20중량% 내지 80중량%의, 아크릴산, 메타크릴산, 이타콘산, 푸마르산, 크로톤산, 아코니트산 또는 말레산, 또는 이들의 조합물을 포함하는 하나 이상의 카르복실산 단량체;2) 80중량% 내지 15중량%의, 하기 화학식의 단량체로부터 선택되는 하나 이상의 α,β-에틸렌계 불포화 단량체:i) CH2 = CXY,ii) CH2 = CH(OCOR1), 및iii) CH2 = CH2 또는 CH2 = CHCH3(상기 식에서,X는 H이며, Y는 -C6H4R', -CN, -CONH2, -Cl, -NC4H6O, NH(CH2)3COOH, -NHCOCH3, -CONHC(CH3)3, -CO-N(CH3)2 이거나,X는 CH3이며, Y는 -C6H4R', -CN 또는 -CH = CH2 이거나,X는 Cl이며, Y는 Cl이며, R'는 H 또는 C1 -18 알킬이고, R1은 C1 -18 알킬이다); 및3) 0.01중량% 내지 5중량%의, 부분적으로 또는 실질적으로 가교된 3차원 망상구조를 형성하는데 유용한 다중불포화 화합물로부터 중합된 중합체를 포함하는 조성물.
- 제 10항에 있어서, 계면활성제의 양이 안정한 조성물의 전체 중량을 기준으로 하여 1중량% 내지 80중량%이며, 공중합체의 양이 수성 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 10중량%인 조성물.
- 제 11항에 있어서, 상기 공중합체가,1) 35중량% 내지 65중량%의 아크릴산 또는 메타크릴산, 또는 이들의 조합물,2) 65중량% 내지 35중량%의 에틸아크릴레이트 또는 메틸아크릴레이트, 또는 이들의 조합물; 및3) 0.03중량% 내지 3중량%의, 수크로오스의 폴리알케닐 에테르 또는 폴리알콜; 또는 트리메틸올프로판 트리(메트)아크릴레이트, 글리시딜 메타크릴레이트, N-메틸올아크릴아미드, 또는 이들의 조합물로부터 유도되는 조성물.
- 제 10항에 있어서, 불용성 실리콘이 폴리디메틸실록산, 아모디메티콘, 아모디메티콘 매크로에멀젼 또는 마이크로에멀젼, 디메티콘, 디메티코놀 (실리콘 검), 시클로메티콘, 페닐트리메티콘, 디메티콘 또는 디메티코놀 마이크로에멀젼 또는 매크로에멀젼, 유기 폴리실록산, 알콕시실리콘, 또는 이들의 조합물이며, 실리콘의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 20중량%인 조성물.
- 제 12항에 있어서, 불용성 실리콘이 폴리디메틸실록산, 아모디메티콘, 아모디메티콘 매크로에멀젼 또는 마이크로에멀젼, 디메티콘, 디메티코놀 (실리콘 검), 시클로메티콘, 페닐트리메티콘, 디메티콘 또는 디메티코놀 마이크로에멀젼 또는 매크로에멀젼, 유기 폴리실록산, 알콕시실리콘, 또는 이들의 조합물이며, 실리콘의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 20중량%인 조성물.
- 제 14항에 있어서, 조성물이 지방산, 지방산 알콜, 지방산 에스테르, 또는 이들의 조합물을 실질적으로 함유하지 않는 조성물.
- a. 하나 이상의 음이온성, 쯔비터 이온성, 양쪽성, 비이온성 또는 양이온성 계면활성제, 또는 이들의 조합물;b. 하나 이상의 실질적으로 가교된 알칼리 팽윤성 아크릴레이트 공중합체 유동성 개질제;c. 물;d. 하나 이상의 광택성 물질; 및e. 최종 pH가 3.8 내지 12가 되도록 하는 유효량의 하나 이상의 중화제를 포 함하는, 개선되거나 증강된 광택성 외관을 나타내는, 안정한 수성 계면활성제 함유 조성물에 있어서,상기 하나 이상의 가교된 알칼리 팽윤성 아크릴레이트 공중합체가,1) 20중량% 내지 80중량%의, 아크릴산, 메타크릴산, 이타콘산, 푸마르산, 크로톤산, 아코니트산 또는 말레산, 또는 이들의 조합물을 포함하는 하나 이상의 카르복실산 단량체;2) 80중량% 내지 15중량%의, 하기 화학식의 단량체로부터 선택되는 하나 이상의 α,β-에틸렌계 불포화 단량체:i) CH2 = CXY,ii) CH2 = CH(OCOR1), 및iii) CH2 = CH2 또는 CH2 = CHCH3(상기 식에서,X는 H이며, Y는 -C6H4R', -CN, -CONH2, -Cl, -NC4H6O, NH(CH2)3COOH, -NHCOCH3, -CONHC(CH3)3, -CO-N(CH3)2 이거나,X는 CH3이며, Y는 -C6H4R', -CN 또는 -CH = CH2 이거나,X는 Cl이며, Y는 Cl이며, R'는 H 또는 C1 -18 알킬이고, R1은 C1 -18 알킬이다); 및3) 0.01중량% 내지 5중량%의, 부분적으로 또는 실질적으로 가교된 3차원 망상구조를 형성하는데 유용한 다중불포화 화합물로부터 중합된 중합체를 포함하는 조성물.
- 제 16항에 있어서, 계면활성제의 양이 안정한 조성물의 전체 중량을 기준으로 하여 1중량% 내지 80중량%이며, 공중합체의 양이 수성 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 10중량%인 조성물.
- 제 17항에 있어서, 상기 공중합체가1) 35중량% 내지 65중량%의 아크릴산 또는 메타크릴산, 또는 이들의 조합물,2) 65중량% 내지 35중량%의 에틸아크릴레이트 또는 메틸아크릴레이트, 또는 이들의 조합물; 및3) 0.03중량% 내지 3중량%의, 수크로오스의 폴리알케닐 에테르 또는 폴리알콜; 또는 트리메틸올프로판 트리(메트)아크릴레이트, 글리시딜 메타크릴레이트, N-메틸올아크릴아미드, 또는 이들의 조합물로부터 유도되는 조성물.
- 제 16항에 있어서, 광택성 물질이 이산화티타늄으로 코팅된 미카, 산화철로 코팅된 미카, 에틸렌글리콜 모노스테아레이트, 에틸렌글리콜 디스테아레이트, 폴리에틸렌 글리콜 디스테아레이트, 비스무트 옥시클로라이드로 코팅된 미카, 미리스틸 미리스테이트, 구아닌 (생선 비늘) 또는 글리터 (폴리에스테르 또는 금속성 물질), 또는 이들의 조합물이며, 광택성 물질의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.05중량% 내지 10중량%인 조성물.
- 제 18항에 있어서, 광택성 물질이 이산화티타늄으로 코팅된 미카, 산화철로 코팅된 미카, 에틸렌글리콜 모노스테아레이트, 에틸렌글리콜 디스테아레이트, 폴리에틸렌 글리콜 디스테아레이트, 비스무트 옥시클로라이드로 코팅된 미카, 미리스틸 미리스테이트, 구아닌 (생선 비늘) 또는 글리터 (폴리에스테르 또는 금속성 물질), 또는 이들의 조합물이며, 광택성 물질의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.05중량% 내지 10중량%인 조성물.
- 제 20항에 있어서, 광택성 물질이 평균 입자 크기가 지름으로 2 내지 150미크론인 이산화티타늄으로 코팅된 미카인 조성물.
- a. 하나 이상의 쯔비터 이온성, 양쪽성, 비이온성 또는 양이온성 계면활성제, 또는 이들의 조합물;b. 하나 이상의 실질적으로 가교된 알칼리 팽윤성 아크릴레이트 공중합체 유동성 개질제;c. 물;d. 하나 이상의 양이온성 모발 염료; 및e. 최종 pH가 5 내지 9가 되도록 하는 유효량의 하나 이상의 중화제를 포함 하는, 안정한 수성의 일시적(temporary) 모발 염료 조성물에 있어서,상기 하나 이상의 가교된 알칼리 팽윤성 아크릴레이트 공중합체가,1) 20중량% 내지 80중량%의, 아크릴산, 메타크릴산, 이타콘산, 푸마르산, 크로톤산, 아코니트산 또는 말레산, 또는 이들의 조합물을 포함하는 하나 이상의 카르복실산 단량체;2) 80중량% 내지 15중량%의, 하기 화학식의 단량체로부터 선택되는 하나 이상의 α,β-에틸렌계 불포화 단량체:i) CH2 = CXY,ii) CH2 = CH(OCOR1), 및iii) CH2 = CH2 또는 CH2 = CHCH3(상기 식에서,X는 H이며, Y는 -C6H4R', -CN, -CONH2, -Cl, -NC4H6O, NH(CH2)3COOH, -NHCOCH3, -CONHC(CH3)3, -CO-N(CH3)2 이거나,X는 CH3이며, Y는 -C6H4R', -CN 또는 -CH = CH2 이거나,X는 Cl이며, Y는 Cl이며, R'는 H 또는 C1 -18 알킬이고, R1은 C1 -18 알킬이다); 및3) 0.01중량% 내지 5중량%의, 부분적으로 또는 실질적으로 가교된 3차원 망 상구조를 형성하는데 유용한 다중불포화 화합물로부터 중합된 중합체를 포함하는 조성물.
- 제 22항에 있어서, 계면활성제의 양이 안정한 조성물의 전체 중량을 기준으로 하여 1중량% 내지 80중량%이며, 공중합체의 양이 수성 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 10중량%인 조성물.
- 제 23항에 있어서, 상기 공중합체가1) 35중량% 내지 65중량%의 아크릴산 또는 메타크릴산, 또는 이들의 조합물,2) 65중량% 내지 35중량%의 에틸아크릴레이트 또는 메틸아크릴레이트, 또는 이들의 조합물; 및3) 0.03중량% 내지 3중량%의, 수크로오스의 폴리알케닐 에테르 또는 폴리알콜; 또는 트리메틸올프로판 트리(메트)아크릴레이트, 글리시딜 메타크릴레이트, N-메틸올아크릴아미드, 또는 이들의 조합물로부터 유도되는 조성물.
- 제 22항에 있어서, 양이온성 모발 염료가 아조 염료 또는 안트라퀴논 염료, 또는 이들의 조합물이며, 모발 염료의 양이 안정화된 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 5중량%인 조성물.
- 제 25항에 있어서, 아조 염료가 베이직 브라운 16(CI 12250), 베이직 브라운 17(CI 12251), 베이직 레드 76(CI 12245), 베이직 옐로 57(CI 12719)이며, 안트라퀴논 염료는 베이직 블루 99(CI 56059)인 조성물.
- 제 24항에 있어서, 양이온성 모발 염료가 아조 염료 또는 안트라퀴논 염료, 또는 이들의 조합물이며, 모발 염료의 양이 안정화된 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 5중량%인 조성물.
- 제 27항에 있어서, 아조 염료가 베이직 브라운 16(CI 12250), 베이직 브라운 17(CI 12251), 베이직 레드 76(CI 12245), 베이직 옐로 57(CI 12719)이며, 안트라퀴논 염료는 베이직 블루 99(CI 56059)인 조성물.
- 제 10항에 있어서, 조성물이 하나 이상의 광택성 물질 또는 하나 이상의 양이온성 모발 염료, 또는 이들의 조합물을 포함하며, 안정한 조성물.
- 제 14항에 있어서, 조성물이 하나 이상의 광택성 물질 또는 하나 이상의 양이온성 모발 염료, 또는 이들의 조합물을 포함하며, 안정한 조성물.
- 제 30항에 있어서, 광택성 물질이 이산화티타늄으로 코팅된 미카, 산화철로 코팅된 미카, 에틸렌글리콜 모노스테아레이트, 에틸렌글리콜 디스테아레이트, 폴리에틸렌 글리콜 디스테아레이트, 비스무트 옥시클로라이드로 코팅된 미카, 미리스틸 미리스테이트, 구아닌 (생선 비늘) 또는 글리터 (폴리에스테르 또는 금속성 물질), 또는 이들의 조합물이며, 광택성 물질의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.05중량% 내지 10중량%인 조성물.
- 제 19항에 있어서, 조성물이 하나 이상의 불용성 실리콘 또는 하나 이상의 가용성 실리콘 또는 하나 이상의 가용성 양이온성 모발 염료, 또는 이들의 조합물을 추가로 함유하며, 안정한 조성물.
- 제 25항에 있어서, 조성물이 하나 이상의 불용성 실리콘 또는 하나 이상의 가용성 실리콘 또는 하나 이상의 광택성 물질, 또는 이들의 조합물을 추가로 함유하며, 안정한 조성물.
- 제 4항에 있어서, 조성물이 개인용 케어 세정 조성물이며, 산이 살리실산 또는 알파-히드록시산이며, 산의 양이 0.2중량% 내지 6중량%인 조성물.
- 제 4항에 있어서, 조성물이 개인용 케어 에멀젼 조성물이며, 산이 알파-히드록시산 또는 베타-히드록시산이며, 산의 양이 0.2중량% 내지 15중량%인 조성물.
- 제 31항에 있어서, 조성물이 개인용 케어 세정 조성물이며, 불용성 실리콘의 양이 0.1중량% 내지 5중량%이며, 광택성 물질의 양이 0.05중량% 내지 3중량%인 조 성물.
- 제 13항에 있어서, 하나 이상의 양이온성 컨디셔닝 중합체를 포함하며, 양이온성 중합체의 양이 0.01중량% 내지 5중량%인 조성물.
- 제 37항에 있어서, 양이온성 컨디셔닝 중합체가 양이온성 구아 검, 폴리콰터늄-4, 폴리콰터늄-6, 폴리콰터늄-7, 폴리콰터늄-10, 폴리콰터늄-11, 폴리콰터늄-16, 폴리콰터늄-24, 폴리콰터늄-39, 또는 이들의 조합물인 조성물.
- 제 37항에 있어서, 하나 이상의 광택성 물질을 포함하는 조성물.
- 제 39항에 있어서, 광택성 물질이 평균 입자 크기가 지름으로 2 내지 150미크론인 이산화티타늄으로 코팅된 미카인 조성물.
- 제 6항에 있어서, 조성물이 비듬방지용 샴푸이며, 현탁 또는 안정화가 요구되는 실질적으로 불용성인 물질이 아연 피리티온이며, 아연 피리티온의 양이 0.1중량% 내지 5중량%인 조성물.
- 제 1항에 있어서, 현탁 또는 안정화가 요구되는, 하나 이상의 실질적으로 불용성인 물질을 포함하며, 상기 실질적으로 불용성인 물질이 실리콘 또는 오일성 물 질 또는 광택성 물질, 또는 이들의 조합물인 조성물.
- 제 42항에 있어서, 불용성 실리콘이 폴리디메틸실록산, 아모디메티콘, 아모디메티콘 매크로에멀젼 또는 마이크로에멀젼, 디메티콘, 디메티코놀 (실리콘 검), 시클로메티콘, 페닐트리메티콘, 디메티콘 또는 디메티코놀 마이크로에멀젼 또는 매크로에멀젼, 유기실록산, 알콕시실리콘, 또는 이들의 조합물이며, 실리콘의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 20중량%인 조성물.
- 제 42항에 있어서, 불용성의 광택성 물질이 이산화티타늄으로 코팅된 미카, 산화철로 코팅된 미카, 에틸렌글리콜 모노스테아레이트, 에틸렌글리콜 디스테아레이트, 폴리에틸렌 글리콜 디스테아레이트, 비스무트 옥시클로라이드로 코팅된 미카, 미리스틸 미리스테이트, 구아닌 (생선 비늘) 또는 글리터 (폴리에스테르 또는 금속성 물질), 또는 이들의 조합물이며, 광택성 물질의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.05중량% 내지 10중량%인 조성물.
- 안정한 수성 계면활성제 함유 조성물을 제조하는 방법으로서,a. 하나 이상의 음이온성, 쯔비터 이온성, 양쪽성, 비이온성 또는 양이온성 계면활성제, 또는 이들의 조합물; 하나 이상의 실질적으로 가교된 알칼리 팽윤성 아크릴레이트 공중합체 유동성 개질제; 및 물을 포함하는 혼합물을 형성하는 단계,b. 혼합물의 pH를 5 내지 14로 증가시키기 위해 유효량의 알칼리성 물질을 사용하여 혼합물을 중화시키는 단계; 및c. 혼합물의 pH를 0.5 내지 5 pH 단위로 감소시키기 위해 유효량의 산성 물질을 첨가시키는 단계를 포함하며,상기 하나 이상의 가교된 알칼리 팽윤성 아크릴레이트 공중합체가1) 20중량% 내지 80중량%의, 아크릴산, 메타크릴산, 이타콘산, 푸마르산, 크로톤산, 아코니트산 또는 말레산, 또는 이들의 조합물을 포함하는 하나 이상의 카르복실산 단량체;2) 80중량% 내지 15중량%의, 하기 화학식의 단량체로부터 선택되는 하나 이상의 α,β-에틸렌계 불포화 단량체:i) CH2 = CXY,ii) CH2 = CH(OCOR1), 및iii) CH2 = CH2 또는 CH2 = CHCH3(상기 식에서,X는 H이며, Y는 -C6H4R', -CN, -CONH2, -Cl, -NC4H6O, NH(CH2)3COOH, -NHCOCH3, -CONHC(CH3)3, -CO-N(CH3)2 이거나,X는 CH3이며, Y는 -C6H4R', -CN 또는 -CH = CH2 이거나,X는 Cl이며, Y는 Cl이며, R'는 H 또는 C1 -18 알킬이고, R1은 C1 -18 알킬이다); 및3) 0.01중량% 내지 5중량%의, 부분적으로 또는 실질적으로 가교된 3차원 망상구조를 형성하는데 유용한 다중불포화 화합물로부터 중합된 중합체를 포함하는 방법.
- 제 45항에 있어서, 실질적으로 가교된 알칼리 팽윤성 중합체의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 10중량%이며, 계면활성제의 양이 안정한 조성물의 전체 중량을 기준으로 하여 1중량% 내지 80중량%인 방법.
- 제 46항에 있어서, 상기 공중합체가a. 35중량% 내지 65중량%의 아크릴산 또는 메타크릴산, 또는 이들의 조합물,b. 65중량% 내지 35중량%의 에틸아크릴레이트 또는 메틸아크릴레이트, 또는 이들의 조합물; 및c. 0.03중량% 내지 3중량%의, 수크로오스의 폴리알케닐 에테르 또는 폴리알콜; 또는 트리메틸올프로판 트리(메트)아크릴레이트, 글리시딜 메타크릴레이트, N-메틸올아크릴아미드, 또는 이들의 조합물로부터 유도되는 방법.
- 제 46항에 있어서, 산성 물질이 시트르산, 아세트산, 베타-히드록시산, 살리실산, 알파-히드록시산, 락트산, 글리콜산, 염산, 황산, 질산, 술팜산 또는 인산 또는 천연 과일산, 또는 이들의 조합물인 방법.
- 제 48항에 있어서, 현탁 또는 안정화가 요구되는 실질적으로 불용성인 물질로 된 안정한 조성물을 형성하는 단계가 포함되며, 상기 실질적으로 불용성인 물질이 실리콘 또는 오일성 물질 또는 광택성 물질, 또는 이들의 조합물인 방법.
- 제 49항에 있어서, 불용성 실리콘이 폴리디메틸실록산, 아모디메티콘, 아모디메티콘 매크로에멀젼 또는 마이크로에멀젼, 디메티콘, 디메티코놀 (실리콘 검), 시클로메티콘, 페닐트리메티콘, 디메티콘 또는 디메티코놀 마이크로에멀젼 또는 매크로에멀젼, 유기 폴리실록산, 알콕시실리콘, 또는 이들의 조합물이며, 실리콘의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.1중량% 내지 20중량%인 방법.
- 제 49항에 있어서, 불용성의 광택성 물질이 이산화티타늄으로 코팅된 미카, 산화철로 코팅된 미카, 에틸렌글리콜 모노스테아레이트, 에틸렌글리콜 디스테아레이트, 폴리에틸렌 글리콜 디스테아레이트, 비스무트 옥시클로라이드로 코팅된 미카, 미리스틸 미리스테이트, 구아닌 (생선 비늘) 또는 글리터 (폴리에스테르 또는 금속성 물질), 또는 이들의 조합물이며, 광택성 물질의 양이 안정한 조성물의 전체 중량을 기준으로 하여 0.05중량% 내지 10중량%인 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/547,595 US6635702B1 (en) | 2000-04-11 | 2000-04-11 | Stable aqueous surfactant compositions |
US09/547,595 | 2000-04-11 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027013606A Division KR100866186B1 (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097014814A Division KR20090088964A (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080027396A true KR20080027396A (ko) | 2008-03-26 |
KR100947959B1 KR100947959B1 (ko) | 2010-03-15 |
Family
ID=24185290
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097014814A KR20090088964A (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
KR1020027013606A KR100866186B1 (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
KR1020087003835A KR100947959B1 (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097014814A KR20090088964A (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
KR1020027013606A KR100866186B1 (ko) | 2000-04-11 | 2001-04-11 | 안정한 수성 계면활성제 조성물 |
Country Status (16)
Country | Link |
---|---|
US (3) | US6635702B1 (ko) |
EP (2) | EP2138561A1 (ko) |
JP (2) | JP5465820B2 (ko) |
KR (3) | KR20090088964A (ko) |
CN (1) | CN100475178C (ko) |
AT (1) | ATE440130T1 (ko) |
AU (2) | AU5759201A (ko) |
BR (1) | BRPI0109990B1 (ko) |
CA (1) | CA2405222C (ko) |
CZ (1) | CZ20023712A3 (ko) |
DE (1) | DE60139613D1 (ko) |
ES (1) | ES2329872T3 (ko) |
MX (1) | MXPA02009941A (ko) |
RU (1) | RU2002130255A (ko) |
WO (1) | WO2001076552A2 (ko) |
ZA (1) | ZA200208119B (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120125632A (ko) * | 2010-02-12 | 2012-11-16 | 로디아 오퍼레이션스 | 유동성 개질제 폴리머 |
KR20130115276A (ko) * | 2010-10-05 | 2013-10-21 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 아크릴레이트 공중합체 증점제 |
Families Citing this family (299)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6533873B1 (en) | 1999-09-10 | 2003-03-18 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Suspending clear cleansing formulation |
US6635702B1 (en) | 2000-04-11 | 2003-10-21 | Noveon Ip Holdings Corp. | Stable aqueous surfactant compositions |
WO2002036095A2 (en) * | 2000-10-31 | 2002-05-10 | Unilever Plc | Personal cleansing composition |
US7256167B2 (en) * | 2001-08-31 | 2007-08-14 | Reckitt Benckiser Inc. | Hard surface cleaner comprising suspended particles and oxidizing agent |
GB2379223A (en) * | 2001-08-31 | 2003-03-05 | Reckitt Benckiser Inc | Cleaning composition comprising citric acid |
GB2398571A (en) * | 2003-02-22 | 2004-08-25 | Reckitt Benckiser Inc | Acidic hard surface cleaning and/or disinfecting composition |
FR2829386B1 (fr) * | 2001-09-11 | 2005-08-05 | Oreal | Compositions cosmetiques contenant un copolymere d'acide methacrylique, une dimethicone, un agent nacrant et un polymere cationique et leurs utilisations |
FR2829384B1 (fr) * | 2001-09-11 | 2003-11-14 | Oreal | Compositions cosmetiques contenant un copolymere d'acide methacrylique, une silicone et un polymere cationique et leurs utilisations |
FR2829387B1 (fr) * | 2001-09-11 | 2005-08-26 | Oreal | Compositions cosmetiques contenant un copolymere d'acide methacrylique, une dimethicone et un polymere cationique et leurs utilisations |
FR2829385B1 (fr) * | 2001-09-11 | 2005-08-05 | Oreal | Compositions cosmetiques contenant un copolymere d'acide methacrylique, une huile et leurs utilisations |
FR2829383B1 (fr) * | 2001-09-11 | 2005-09-23 | Oreal | Compositions cosmetiques contenant un copolymere d'acide methacrylique, une silicone et un polymere cationique et leurs utilisations |
DE10150729A1 (de) * | 2001-10-13 | 2003-04-17 | Cognis Deutschland Gmbh | Kosmetische und/oder pharmazeutische Zubereitungen |
WO2003059297A2 (en) * | 2002-01-21 | 2003-07-24 | Slovakofarma A.S. | Dermatological topical compositions and a process for the preparation thereof |
US7498022B2 (en) * | 2002-03-28 | 2009-03-03 | L'oreal S.A. | Cosmetic composition comprising at least one anionic surfactant, at least one cationic polymer and at least one amphiphilic, branched block acrylic copolymer and method for treating hair using such a composition |
FR2839516B1 (fr) * | 2002-05-13 | 2006-08-04 | Pierre Bruno Grascha | Formulation de detergent d'atelier |
EP1792973A1 (en) * | 2002-05-21 | 2007-06-06 | The Procter & Gamble Company | Cleaning compositions comprising suspended beads |
DE10224024A1 (de) * | 2002-05-31 | 2003-12-11 | Beiersdorf Ag | Getrübtes Pflegeshampoo |
DE10227868A1 (de) * | 2002-06-22 | 2004-01-08 | Beiersdorf Ag | Cremiger Haarfestiger |
US20040185016A1 (en) * | 2002-07-30 | 2004-09-23 | Popp Karl F | Compositions for treatment of hyperpigmentation and methods for making and using such compositions |
US20040052748A1 (en) * | 2002-09-06 | 2004-03-18 | Vondruska Brian Jay | Compositions of anionic polymeric rheology modifiers and cationic materials |
AU2003277111B2 (en) * | 2002-10-09 | 2006-10-19 | The Procter & Gamble Company | Cosmetic compositions with reduced tack |
US7402549B2 (en) * | 2004-01-21 | 2008-07-22 | Schlumberger Technology Corporation | Viscoelastic surfactant rheology modification |
US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
US7708981B2 (en) * | 2003-03-11 | 2010-05-04 | L'oreal S.A. | Cosmetic compositions comprising at least one crosslinked copolymer, at least one insoluble mineral particle and at least one polymer, and uses thereof |
FR2852238B1 (fr) * | 2003-03-11 | 2006-07-28 | Oreal | Compositions cosmetiques comprenant un copolymere d'acide methacrylique, des particules minerales insolubles et un polymere cationique et leurs utilisations |
FR2852237B1 (fr) * | 2003-03-11 | 2006-07-14 | Oreal | Compositions cosmetiques contenant un copolymere d'acide methacrylique, une cyclodextrine et un tensioactif et leurs utilisations |
CA2521479C (en) | 2003-04-14 | 2010-02-09 | The Procter & Gamble Company | Anhydrous, transfer-resistant cosmetic lip compositions |
GB0314210D0 (en) * | 2003-06-18 | 2003-07-23 | Unilever Plc | Laundry treatment compositions |
US7326676B2 (en) * | 2003-07-11 | 2008-02-05 | The Procter & Gamble Company | Liquid laundry detergent compositions with silicone fabric care agents |
US7119059B2 (en) * | 2003-08-28 | 2006-10-10 | Johnson & Johnson Consumer Companies, Inc. | Mild and effective cleansing compositions |
US7098180B2 (en) * | 2003-08-28 | 2006-08-29 | Johnson & Johnson Consumer Companies Inc. | Mild and effective cleansing compositions |
BR0303286B1 (pt) * | 2003-08-29 | 2013-08-20 | microemulsço cosmÉtica. | |
DE10344527A1 (de) * | 2003-09-25 | 2005-04-21 | Beiersdorf Ag | Schäumende Zubereitungen mit Fließgrenze |
US8980235B2 (en) * | 2003-09-30 | 2015-03-17 | Arch Chemicals, Inc. | Coated metal pyrithione particles for treatment of microorganisms |
US20050090414A1 (en) * | 2003-10-23 | 2005-04-28 | Sarah Rich | Color changing hand soap composition |
CN100502832C (zh) * | 2003-10-27 | 2009-06-24 | 荷兰联合利华有限公司 | 护发组合物 |
US20050118058A1 (en) * | 2003-12-01 | 2005-06-02 | Erning Xia | Gentle preservative compositions for self-preserving solutions |
EP1537847B1 (en) * | 2003-12-05 | 2011-01-26 | KPSS-Kao Professional Salon Services GmbH | Conditioning and cleansing composition for hair |
US20050137102A1 (en) * | 2003-12-17 | 2005-06-23 | Kimberly-Ckark Worldwide, Inc. | Foamable industrial strength hand cleanser |
US20050142084A1 (en) * | 2003-12-29 | 2005-06-30 | Sanjoy Ganguly | Cosmetic compositions containing nacreous pigments of large sized synthetic mica |
WO2005092273A2 (en) * | 2004-03-04 | 2005-10-06 | Noveon Ip Holdings Corp. | Method of compatibilizing cationic materials with anionic polymers |
US20050201965A1 (en) * | 2004-03-11 | 2005-09-15 | The Procter & Gamble Company | Personal cleansing compositions |
US7585426B2 (en) * | 2004-03-26 | 2009-09-08 | Arrowstar, Llc | Compositions and methods for imparting stain resistance, liquid repellency, and enhanced antimicrobial activity to an article and articles thereof |
US7446081B2 (en) * | 2004-03-31 | 2008-11-04 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Rinse-off facial wash compositions delivering enhanced whitening using submicron titanium oxide, optional modifier and deposition system |
US7442674B2 (en) * | 2004-03-31 | 2008-10-28 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Beauty wash product compositions delivering enhanced visual benefits to the skin with specific optical attributes |
US20050220736A1 (en) * | 2004-03-31 | 2005-10-06 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Beauty wash product compositions delivering enhanced visual benefits to the skin with specific optical attributes |
ATE437896T1 (de) * | 2004-04-06 | 2009-08-15 | Ciba Holding Inc | Flüssige dispersionspolymerzusammensetzungen, ihre herstellung und ihre verwendung |
BRPI0509870A (pt) * | 2004-04-16 | 2007-10-23 | Procter & Gamble | composições detergentes lìquidas para lavagem de roupas com misturas de silicones como agentes para tratamento de tecidos |
FR2869534B1 (fr) * | 2004-04-30 | 2008-08-29 | Oreal | Composition detergente comprenant un tensioactif non ionique et un polymere anionique et utilisation pour proteger la couleur |
NZ551546A (en) | 2004-05-07 | 2010-07-30 | Deb Ip Ltd | Foamed cleanser with suspended particles, a method of producing same, and a dispenser therefore |
DE102004034915A1 (de) | 2004-07-14 | 2006-04-06 | Beiersdorf Ag | Reinigungsgel |
MY140238A (en) * | 2004-07-20 | 2009-12-31 | Colgate Palmolive Co | Liquid cleansing compositions |
RU2377971C2 (ru) * | 2004-07-21 | 2010-01-10 | Колгейт-Палмолив Компани | Структурированный состав для мытья тела |
KR100694861B1 (ko) * | 2004-08-25 | 2007-03-14 | 롬 앤드 하아스 컴패니 | 고-pH 수성 시스템용 증점제 |
US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
BRPI0504779A (pt) * | 2004-11-08 | 2006-06-27 | Rohm & Haas | composição aquosa, método de preparação da mesma, e, formulação aquosa |
EP1656967B1 (en) * | 2004-11-09 | 2011-03-30 | KPSS-Kao Professional Salon Services GmbH | Color enhancing shampoo composition |
US7776318B2 (en) * | 2004-11-26 | 2010-08-17 | L'oreal S.A. | Liquid cleaning composition comprising at least one anionic surfactant and its use for cleansing human keratin materials |
FR2878441B1 (fr) | 2004-11-26 | 2008-09-19 | Oreal | Composition liquide de nettoyage a base de tensioactifs anioniques ; utilisations pour le nettoyage des matieres keratiniques humaines |
JP5179191B2 (ja) * | 2004-12-02 | 2013-04-10 | ザ プロクター アンド ギャンブル カンパニー | 高分子増粘毛髪染色及び漂白組成物 |
ATE473034T1 (de) * | 2004-12-16 | 2010-07-15 | Kpss Kao Gmbh | Reinigungsmittel |
US20060135383A1 (en) * | 2004-12-17 | 2006-06-22 | Cossa Anthony J | Cleansing compositions comprising polymeric emulsifiers and methods of using same |
US20060134052A1 (en) * | 2004-12-17 | 2006-06-22 | Cossa Anthony J | Compositions comprising polymeric emulsifiers and methods of using same |
GB2421432A (en) * | 2004-12-23 | 2006-06-28 | Cosmetic Warriors Ltd | Cosmetic jelly |
EP1690878B1 (en) * | 2005-02-14 | 2007-09-12 | Rohm and Haas Company | Thickener for aqueous systems |
JP5084143B2 (ja) * | 2005-02-14 | 2012-11-28 | 株式会社Adeka | 光安定剤乳化組成物 |
DE102005013489A1 (de) | 2005-03-21 | 2006-09-28 | Henkel Kgaa | Haarreinigungsmittel mit optimiertem Fließverhalten |
DE102005014423A1 (de) * | 2005-03-24 | 2006-09-28 | Beiersdorf Ag | Pflegesystem aus PVP- und Acrylatpolymeren |
EP1874914B1 (en) * | 2005-04-21 | 2012-09-26 | Colgate-Palmolive Company | Liquid detergent composition |
EP1719546B2 (en) * | 2005-05-04 | 2016-07-13 | Kao Germany GmbH | Hair conditioning composition |
US20060280096A1 (en) * | 2005-05-26 | 2006-12-14 | Inphase Technologies, Inc. | Erasing holographic media |
WO2006130510A2 (en) | 2005-05-27 | 2006-12-07 | Taro Pharmaceuticals U.S.A., Inc. | Stable liquid desoximethasone compositions with reduced oxidized impurity |
AR057044A1 (es) | 2005-05-31 | 2007-11-14 | Rhodia | Composiciones con modificadores de reologia hase |
US20060275333A1 (en) * | 2005-06-03 | 2006-12-07 | Humco Holding Group, Inc. | Composition with beads for treatment of contact dermatitis |
AU2006280019A1 (en) * | 2005-08-09 | 2007-02-22 | Soane Labs, Llc | Hair hold formulations |
GT200600375A (es) | 2005-08-17 | 2007-03-14 | Composición limpiadora ácida que contiene un polímero de hidrofilización | |
US7270131B2 (en) * | 2005-09-06 | 2007-09-18 | Edward Hocking | Hard surface cleaning composition |
US20070148213A1 (en) * | 2005-12-22 | 2007-06-28 | Sayed Ibrahim | Film containing compositions |
US20070179078A1 (en) * | 2006-01-30 | 2007-08-02 | Collin Jennifer R | Rheology modifier for aqueous systems |
US20090165976A1 (en) * | 2006-02-03 | 2009-07-02 | Nanopaper, Llc | Expansion agents for paper-based materials |
WO2007092450A2 (en) | 2006-02-03 | 2007-08-16 | Nanopaper Llc | Functionalization of paper components |
JP5558721B2 (ja) * | 2006-02-24 | 2014-07-23 | ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド | シリコーンコポリオールマクロマーを含むポリマーおよびそのポリマーを含むパーソナルケア組成物 |
CN101389694B (zh) * | 2006-02-24 | 2013-03-27 | 路博润高级材料公司 | 可聚合的硅氧烷共聚醇大分子单体和由其制成的聚合物 |
US20070203040A1 (en) * | 2006-02-24 | 2007-08-30 | Harry Reicherz | Bar soap |
US20070213243A1 (en) * | 2006-03-08 | 2007-09-13 | Ge Yao | Stable Soap Based Cleansing System |
CN101404973A (zh) | 2006-03-22 | 2009-04-08 | 宝洁公司 | 包括含有颗粒物质的发泡母料组合物的气溶胶产品 |
ES2376125T3 (es) | 2006-03-22 | 2012-03-09 | The Procter & Gamble Company | Composición de tratamiento l�?quida. |
MX2008013279A (es) * | 2006-04-20 | 2008-10-27 | Dial Corp | Sistema de suministro para un agente higienico. |
US7771542B1 (en) | 2006-05-30 | 2010-08-10 | Stone Chemical Company | Compositions and methods for removing lead from metal surfaces |
US20080050320A1 (en) * | 2006-08-23 | 2008-02-28 | Ariel Haskel | Skin care compositions containing a hydrophobic material and related methods |
US20080070823A1 (en) * | 2006-09-15 | 2008-03-20 | Philip Gorlin | Liquid Detergent Composition |
DE102006044942A1 (de) * | 2006-09-22 | 2008-04-03 | Beiersdorf Ag | Peelingkapseln |
US7820563B2 (en) | 2006-10-23 | 2010-10-26 | Hawaii Nanosciences, Llc | Compositions and methods for imparting oil repellency and/or water repellency |
KR100834808B1 (ko) | 2006-11-02 | 2008-06-10 | (주)인비티 | 클렌징 조성물 |
EP1925286A1 (en) * | 2006-11-24 | 2008-05-28 | KPSS-Kao Professional Salon Services GmbH | Cleansing composition |
CN101535350B (zh) * | 2006-11-09 | 2012-04-04 | 路博润高级材料公司 | 刺激缓和的聚合物和其用途 |
WO2008071965A1 (en) * | 2006-12-14 | 2008-06-19 | Chartered Brands Limited | Aqueous mica suspension |
MY150444A (en) * | 2006-12-15 | 2014-01-30 | Colgate Palmolive Co | Liquid detergent composition |
US20080206359A1 (en) * | 2007-02-23 | 2008-08-28 | Nikita Wilson | Day and Night Composition and method for treating Pseudofolliculitis Barbae |
ES2377160T3 (es) * | 2007-03-20 | 2012-03-23 | The Procter & Gamble Company | Método para lavar ropa o limpiar superficies duras |
US20080242581A1 (en) * | 2007-04-02 | 2008-10-02 | Colgate-Palmolive Company | Liquid Detergent With Refractive Particle |
CL2008001991A1 (es) * | 2007-07-06 | 2009-09-25 | Basf Se | Uso de homo y copolimeros que comprenden al menos 10% en peso de un monomero seleccionado entre acido acrilico y metacrilico y hasta 90% de uno o mas monomeros no ionicos, donde la suma de ambos es de al menos el 70% de los monomeros; composicion y preparacion del principio activo; dispersion acuosa y su preparacion. |
WO2009015857A2 (de) * | 2007-08-02 | 2009-02-05 | Clariant International Ltd | Wässrige zusammensetzungen enthaltend alkoxylierte phosphorsäuretriester |
WO2009078857A1 (en) * | 2007-12-17 | 2009-06-25 | Colgate-Palmolive Company | Cleansing bars |
WO2009085838A1 (en) * | 2007-12-31 | 2009-07-09 | Isp Investments Inc. | Method of protecting dyed hair color from fading or wash-out |
US7939479B2 (en) * | 2008-03-12 | 2011-05-10 | Chandler Barry E | Dry hand cleaner comprising corncob particles |
US9376648B2 (en) * | 2008-04-07 | 2016-06-28 | The Procter & Gamble Company | Foam manipulation compositions containing fine particles |
CN101591502B (zh) * | 2008-05-30 | 2011-12-14 | 比亚迪股份有限公司 | 一种聚氨酯涂料及其制备方法 |
US7757657B2 (en) * | 2008-09-11 | 2010-07-20 | Gm Global Technology Operations, Inc. | Dual active fuel management sequencing |
US8394752B2 (en) * | 2008-12-18 | 2013-03-12 | The Procter & Gamble Company | Pearlescent agent slurry for liquid treatment composition |
WO2010080326A1 (en) † | 2008-12-18 | 2010-07-15 | The Procter & Gamble Company | Pearlescent agent slurry for liquid treatment composition |
US7578857B1 (en) | 2008-12-24 | 2009-08-25 | Combe Incorporated | Color shampoo formula |
BRPI1005145A2 (pt) * | 2009-01-21 | 2018-02-20 | Vanangamudi Subramaniam Sulur | creme dermaceutico composto por fusidato de sodio e esteroides |
US20110281831A1 (en) * | 2009-01-21 | 2011-11-17 | Apex Laboratories Private Limited | Novel dermaceutical cream made using sodium fusidate, antifungals and steroids |
WO2010121876A1 (en) | 2009-04-22 | 2010-10-28 | Unilever Plc | Composition |
EP2248510A1 (en) * | 2009-05-07 | 2010-11-10 | Rohm and Haas Company | Thickened aqueous composition |
JP5562594B2 (ja) * | 2009-08-07 | 2014-07-30 | 花王株式会社 | 皮膚洗浄剤組成物 |
US8017566B2 (en) * | 2009-11-13 | 2011-09-13 | Conopco, Inc. | Liquid personal cleansing composition |
CA2781923C (en) | 2009-12-03 | 2018-08-14 | Opko Health, Inc. | Hypersulfated disaccharide formulations |
CA2820892C (en) * | 2010-02-12 | 2019-12-03 | Rhodia Operations | Compositions with freeze thaw stability |
US8969261B2 (en) * | 2010-02-12 | 2015-03-03 | Rhodia Operations | Rheology modifier compositions and methods of use |
EP2368923B1 (en) | 2010-03-23 | 2013-05-01 | Rohm and Haas Company | Method for producing hydrophobically modified acrylic rheology modifiers |
US20110277796A1 (en) * | 2010-05-13 | 2011-11-17 | Russel Walters | Method of cleansing skin having an impaired barrier |
DE102010022063A1 (de) | 2010-05-31 | 2011-12-01 | Beiersdorf Ag | Neues verdickendes Polymer |
CA2800537C (en) | 2010-06-11 | 2016-02-09 | The Procter & Gamble Company | Compositions for treating skin |
US8343902B2 (en) | 2010-06-24 | 2013-01-01 | Johnson & Johnson Consumer Companies, Inc. | Low-irritating, clear cleansing compositions with relatively low pH |
US8329626B2 (en) | 2010-06-24 | 2012-12-11 | Johnson & Johnson Consumer Companies, Inc. | Low-irritating, clear cleansing compositions with relatively low pH |
US8329627B2 (en) | 2010-06-24 | 2012-12-11 | Johnson & Johnson Consumer Companies, Inc. | Low-irritating, clear cleansing compositions with relatively low pH |
MX2013000240A (es) | 2010-07-09 | 2013-02-07 | Lubrizol Advanced Mat Inc | Mezclas de espesantes de copolimero acrilico. |
EP2591027B1 (en) | 2010-07-09 | 2015-09-23 | Lubrizol Advanced Materials, Inc. | Structured acrylate copolymer thickeners |
US8921295B2 (en) | 2010-07-23 | 2014-12-30 | American Sterilizer Company | Biodegradable concentrated neutral detergent composition |
CN103025834A (zh) * | 2010-08-03 | 2013-04-03 | 道康宁公司 | 有机硅胶乳液 |
EP2415879A1 (de) | 2010-08-06 | 2012-02-08 | LANXESS Deutschland GmbH | Zusammensetzungen enthaltend wenigstens eine Carbamoylsulfonatgruppen-haltige Verbindung und ihre Verwendung als Gerbstoffe |
WO2012030750A2 (en) * | 2010-09-02 | 2012-03-08 | Lubrizol Advanced Materials, Inc. | Polymers and compositions |
MX2013003421A (es) | 2010-09-30 | 2013-10-01 | Lubrizol Advanced Mat Inc | Copolimero de acrilato estructurado para uso en sistemas de multi-fase. |
US8974589B2 (en) * | 2010-10-25 | 2015-03-10 | The Armor All/Stp Products Company | Silicone protectant compositions |
FR2968934B1 (fr) * | 2010-12-20 | 2015-03-27 | Oreal | Composition comprenant un colorant naturel et/ou un colorant direct cationique et/ou non ionique, un silicate insoluble et un mono- ou poly- glycoside |
US8623790B2 (en) | 2010-12-21 | 2014-01-07 | Newpark Drilling Fluids Llc | Method of drilling a subterranean well with crosslinked polyacrylic acid |
US8338348B2 (en) | 2010-12-21 | 2012-12-25 | Johnson & Johnson Consumer Companies, Inc. | Skin cleansing compositions with polyglycerol esters and hydrophobically modified polymers |
FR2972349B1 (fr) | 2011-03-07 | 2013-04-05 | Coatex Sas | Formulation cosmetique contenant un copolymere amphiphile non hydrosoluble comme agent epaississant. |
US8569218B2 (en) * | 2011-03-07 | 2013-10-29 | Illinois Tool Works, Inc. | Cleaning composition containing polymer microemulsion |
FR2972370B1 (fr) * | 2011-03-07 | 2013-03-01 | Coatex Sas | Procede d'epaississement d'une formulation cosmetique a partir d'une emulsion alkali gonflable d'un polymere a l'amps et riche en acide acrylique. |
CN103415324B (zh) * | 2011-03-10 | 2016-04-20 | 荷兰联合利华有限公司 | 包含吡啶硫酮和基于氯氧化铋的珠光剂体系的头发护理组合物 |
EP2683446B1 (en) | 2011-03-10 | 2014-12-03 | Unilever N.V. | Hair care composition comprising pyrithione and a pearliser system based on bismuth oxychloride |
BR112013022732B1 (pt) * | 2011-03-10 | 2018-03-13 | Unilever N.V. | Composição para o cuidado dos cabelos |
ITVA20110008A1 (it) | 2011-03-25 | 2012-09-26 | Lamberti Spa | Composizioni detergenti |
DE102011078087A1 (de) | 2011-06-27 | 2012-12-27 | Beiersdorf Ag | Neues verdickendes Polymer II |
US9232790B2 (en) | 2011-08-02 | 2016-01-12 | Kimberly-Clark Worldwide, Inc. | Antimicrobial cleansing compositions |
MX2014002087A (es) | 2011-08-23 | 2015-09-07 | Vive Crop Prot Inc | Formulaciones piretroides. |
EP2747841A2 (en) * | 2011-08-25 | 2014-07-02 | Unilever N.V. | Hair conditioning composition comprising a blend of metal pyrithione with a non-anionic surfactant and further comprising a silicone |
CN103890131A (zh) | 2011-09-13 | 2014-06-25 | 路博润高级材料公司 | 表面活性剂响应性乳液聚合的微凝胶 |
EP2756051B2 (en) | 2011-09-13 | 2019-06-12 | Lubrizol Advanced Materials, Inc. | Surfactant responsive micro-gels |
US9714376B2 (en) | 2011-09-13 | 2017-07-25 | Lubrizol Advanced Materials, Inc. | Surfactant responsive dispersion polymerized micro-gels |
US20130149273A1 (en) | 2011-12-09 | 2013-06-13 | The Procter & Gamble Company | Personal Care Compositions |
CN103156796A (zh) * | 2011-12-14 | 2013-06-19 | 吴江市冰心文教用品有限公司 | 一种染发颜料及其生产方法 |
DE102011089222A1 (de) * | 2011-12-20 | 2013-06-20 | Henkel Ag & Co. Kgaa | Mittel zum Färben von keratinischen Fasern enthaltend kationische Anthrachinonfarbstoffe und Fettsäurediester von Alkandiolen |
CN104080333B (zh) | 2011-12-22 | 2017-06-23 | 维弗作物保护公司 | 嗜球果伞素配制品 |
US8895041B2 (en) | 2012-03-23 | 2014-11-25 | The Procter & Gamble Company | Compositions for delivering perfume to the skin |
US8865147B2 (en) * | 2012-04-30 | 2014-10-21 | L'oreal | Hair cleansing and conditioning composition |
CN104540494B (zh) | 2012-05-30 | 2017-10-24 | 科莱恩金融(Bvi)有限公司 | N‑甲基‑n‑酰基葡糖胺作为增溶剂的用途 |
JP6729925B2 (ja) | 2012-05-30 | 2020-07-29 | クラリアント・ファイナンス・(ビーブイアイ)・リミテッド | N−メチル−n−アシルグルカミン含有組成物 |
WO2013186695A1 (en) | 2012-06-11 | 2013-12-19 | Vive Crop Protection Inc. | Herbicide formulations |
DE102012212127A1 (de) | 2012-07-11 | 2014-01-16 | Henkel Ag & Co. Kgaa | Ein Verdicker und dessen Verwendung, insbesondere in oxidativen Haarbehandlungsmitteln |
WO2014018309A1 (en) | 2012-07-26 | 2014-01-30 | The Procter & Gamble Company | Low ph liquid cleaning compositions with enzymes |
US20140039066A1 (en) * | 2012-08-03 | 2014-02-06 | Piped Limited | Formulation for gritty foam dispenser |
US9145340B2 (en) | 2012-08-13 | 2015-09-29 | Verdesian Life Sciences, Llc | Method of reducing atmospheric ammonia in livestock and poultry containment facilities |
JP2014047313A (ja) * | 2012-09-03 | 2014-03-17 | Pureson Corp | 液体洗浄剤及びその製造方法 |
US8721740B2 (en) | 2012-10-02 | 2014-05-13 | L'oreal | Agent for altering the color of keratin fibers containing a fatty substance and a rheology modifying polymer in a neutral to acidic system |
US8721742B2 (en) | 2012-10-02 | 2014-05-13 | L'oreal | Agent for altering the color of keratin fibers comprising a fatty substance, a rheology modifying polymer, and direct dyes in a liquid emulsion system |
US8721739B2 (en) | 2012-10-02 | 2014-05-13 | L'oreal | Agent for altering the color of keratin fibers containing a fatty substance and a rheology modifying polymer in an alkaline system |
US8721741B2 (en) | 2012-10-02 | 2014-05-13 | L'oreal | Agent for altering the color of keratin fibers containing a fatty substance, a rheology modifying polymer, and direct dyes in a cream emulsion system |
DE102012218091A1 (de) | 2012-10-04 | 2014-04-10 | Beiersdorf Ag | Kosmetische Reinigungszubereitung mit neuartigem Assoziativverdicker |
US10413496B2 (en) | 2012-10-15 | 2019-09-17 | L'oreal | Aqueous wax dispersions |
US9961922B2 (en) | 2012-10-15 | 2018-05-08 | Verdesian Life Sciences, Llc | Animal feed and/or water amendments for lowering ammonia concentrations in animal excrement |
US9408785B2 (en) | 2012-10-15 | 2016-08-09 | L'oreal | Hair styling compositions containing aqueous wax dispersions |
US10626294B2 (en) | 2012-10-15 | 2020-04-21 | L'oreal | Aqueous wax dispersions containing volatile solvents |
DE102012021647A1 (de) | 2012-11-03 | 2014-05-08 | Clariant International Ltd. | Wässrige Adjuvant-Zusammensetzungen |
CN104884040B (zh) * | 2012-11-29 | 2017-11-10 | 荷兰联合利华有限公司 | 包含反射颗粒的结构化液体 |
US20140161755A1 (en) | 2012-12-10 | 2014-06-12 | L'oreal | Clear cleansing composition |
DE102012222956A1 (de) * | 2012-12-12 | 2014-06-12 | Beiersdorf Ag | Kosmetische Zubereitungen mit Fließgrenze |
EP2935358A4 (en) | 2012-12-21 | 2016-05-11 | Rhodia Operations | DEPOSITS AND METHODS OF PREVENTING THEM AND METHOD OF USE THEREOF |
EP2935359A4 (en) | 2012-12-21 | 2016-06-15 | Rhodia Operations | COMPOSITIONS WITH PH-SENSITIVE COPOLYMER CONTAINING MAEP AND / OR MAHP AND METHODS OF USING THE SAME |
US8574561B1 (en) | 2012-12-21 | 2013-11-05 | L'oreal | Compositions containing anti-dandruff agents |
WO2014122598A1 (en) | 2013-02-05 | 2014-08-14 | Vive Crop Protection Inc. | Mectin and milbemycin formulations |
EP2964181B1 (en) | 2013-03-08 | 2018-05-30 | Lubrizol Advanced Materials, Inc. | Polymers and methods to mitigate the loss of silicone deposition from keratinous substrates |
US10918589B2 (en) * | 2013-03-15 | 2021-02-16 | John Robert Goepfert | Personal-lubricating material and method for lubricant manufacture |
WO2014206554A2 (de) * | 2013-06-28 | 2014-12-31 | Clariant International Ltd | Verwendung von speziellen n-methyl-n-acylglucaminen in hautreinigungsmitteln und handgeschirrspülmitteln |
US20150030644A1 (en) * | 2013-07-26 | 2015-01-29 | The Procter & Gamble Company | Amino Silicone Nanoemulsion |
US11254620B2 (en) | 2013-08-05 | 2022-02-22 | Verdesian Life Sciences U.S., Llc | Micronutrient-enhanced polymeric seed coatings |
TW201522390A (zh) | 2013-08-27 | 2015-06-16 | 特級肥料產品公司 | 聚陰離子聚合物 |
WO2015035031A1 (en) | 2013-09-05 | 2015-03-12 | Verdesian Life Sciences, Llc | Polymer-boric acid compositions |
US8920521B1 (en) | 2013-10-01 | 2014-12-30 | L'oreal | Agent for altering the color of keratin fibers comprising a rheology modifying polymer and high levels of a fatty substance in a cream system |
US8915973B1 (en) | 2013-10-01 | 2014-12-23 | L'oreal | Agent for altering the color of keratin fibers containing a rheology modifying polymer and a fatty substance in an alkaline cream system |
WO2015059711A1 (en) * | 2013-10-25 | 2015-04-30 | Galaxy Surfactants Ltd. | Sustainable cold-dispersible pearlescent concentrate |
US9914797B2 (en) | 2013-11-13 | 2018-03-13 | Rohm And Haas Chemicals Llc | Alkali-swellable crosslinked acrylate copolymer, methods of manufacture thereof, and composition comprising the same |
TW201529696A (zh) | 2013-12-17 | 2015-08-01 | Lubrizol Advanced Mat Inc | 界面活性劑敏感性乳化聚合微膠體 |
CN106068143A (zh) * | 2013-12-23 | 2016-11-02 | 路博润先进材料公司 | 用于去屑护发组合物的悬浮剂和稳定剂 |
US20150210964A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Consumer Product Compositions |
JP2015178466A (ja) | 2014-03-19 | 2015-10-08 | ロレアル | 内部オレフィンスルホン酸塩及び1種のポリマー懸濁剤を含有する起泡性組成物 |
DE102014104261B4 (de) | 2014-03-26 | 2024-05-16 | Symrise Ag | Verdickte transparente Tensidsysteme mit Fließgrenze, enthaltend 4-Hydroxyacetophenon |
US10561596B2 (en) | 2014-04-11 | 2020-02-18 | L'oreal | Compositions and dispersions containing particles comprising a polymer |
DE102014005771A1 (de) | 2014-04-23 | 2015-10-29 | Clariant International Ltd. | Verwendung von wässrigen driftreduzierenden Zusammensetzungen |
US20150320674A1 (en) * | 2014-05-08 | 2015-11-12 | Micro Powders, Inc. | Compositions Comprising Synthetic Waxes |
US20150328103A1 (en) * | 2014-05-15 | 2015-11-19 | The Dial Corporation | Exfoliating anti-acne face cleansing composition |
WO2015179687A1 (en) | 2014-05-21 | 2015-11-26 | Verdesian Life Sciences, Llc | Polymer soil treatment compositions including humic acids |
US10822487B2 (en) | 2014-05-22 | 2020-11-03 | Verdesian Life Sciences Llc | Polymeric compositions |
JP6666062B2 (ja) | 2014-05-30 | 2020-03-13 | ロレアル | 起泡性クレンジング |
WO2016001060A1 (en) * | 2014-07-03 | 2016-01-07 | L'oreal | Cosmetic composition for caring for keratin fibers, process for cosmetic treatment and use thereof for cleansing and conditioning the keratin fibers |
JP2016056110A (ja) * | 2014-09-05 | 2016-04-21 | ロレアル | ケラチン繊維用の化粧用組成物 |
CN107148263B (zh) | 2014-11-10 | 2021-07-06 | 宝洁公司 | 个人护理组合物 |
WO2016077327A1 (en) | 2014-11-10 | 2016-05-19 | The Procter & Gamble Company | Personal care compositions with two benefit phases |
US11207248B2 (en) | 2014-11-10 | 2021-12-28 | The Procter And Gamble Company | Personal care compositions with two benefit phases |
US10966916B2 (en) | 2014-11-10 | 2021-04-06 | The Procter And Gamble Company | Personal care compositions |
JP6450157B2 (ja) * | 2014-11-12 | 2019-01-09 | 株式会社ダリヤ | 毛髪一時着色剤組成物 |
JP2018020961A (ja) * | 2014-11-21 | 2018-02-08 | ライオン株式会社 | シャンプー組成物 |
FR3029787B1 (fr) | 2014-12-10 | 2019-11-29 | L'oreal | Composition nettoyante a base a base d'un polyethylenegycol, d'un polyether ester et d'un agent de suspension polymerique |
KR20170096170A (ko) | 2014-12-17 | 2017-08-23 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 계면활성제 반응성 에멀젼 중합 마이크로-겔 |
JP2017538732A (ja) | 2014-12-18 | 2017-12-28 | ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド | フケ防止用ヘアケア組成物のための両親媒性懸濁安定剤 |
JP2016190820A (ja) * | 2015-03-31 | 2016-11-10 | ロート製薬株式会社 | 毛髪の染色性を増強させるための毛髪洗浄組成物 |
BR112017022021B1 (pt) | 2015-04-23 | 2021-07-06 | The Procter & Gamble Company | Composição para tratamento dos cabelos |
US10245221B2 (en) | 2015-05-07 | 2019-04-02 | Celeb LLC | Stabilized color depositing shampoo |
US9889080B2 (en) | 2015-05-07 | 2018-02-13 | Celeb LLC | Color depositing shampoo |
US9937118B2 (en) | 2016-06-21 | 2018-04-10 | Johnson & Johnson Consumer Inc. | Clear suspending personal care cleansing compositions |
PT108665B (pt) * | 2015-07-05 | 2020-11-02 | Universidade Do Minho | Micro ou nanocápsulas com propriedades fotocatalíticas para libertação controlada de agentes difusores e respetivo método de obtenção |
FR3039396B1 (fr) * | 2015-07-28 | 2017-08-11 | Laboratoires M&L | Base de formulation cosmetique concentree |
DE102015216603A1 (de) * | 2015-08-31 | 2017-03-02 | Henkel Ag & Co. Kgaa | Zusammensetzung zur Hautpflege |
JP6949714B2 (ja) * | 2015-09-30 | 2021-10-13 | 株式会社 資生堂 | 水中油中粉体型組成物 |
DE102015219309B4 (de) * | 2015-10-06 | 2018-01-18 | Henkel Ag & Co. Kgaa | Formstabile, abreibbare Zubereitung enthaltend plättchenförmige Partikel |
DE102015219651A1 (de) | 2015-10-09 | 2017-04-13 | Clariant International Ltd. | Zusammensetzungen enthaltend Zuckeramin und Fettsäure |
DE202015008045U1 (de) | 2015-10-09 | 2015-12-09 | Clariant International Ltd. | Universelle Pigmentdispersionen auf Basis von N-Alkylglukaminen |
WO2017106403A1 (en) * | 2015-12-15 | 2017-06-22 | The Procter & Gamble Company | Hair cleansing composition |
WO2017112586A1 (en) | 2015-12-23 | 2017-06-29 | Lubrizol Advanced Materials, Inc. | Hydrophobically modified alkali-swellable emulsion polymers |
WO2017112584A2 (en) | 2015-12-23 | 2017-06-29 | Lubrizol Advanced Materials, Inc. | Alkali-swellable emulsion polymers |
US20190040172A1 (en) * | 2016-02-04 | 2019-02-07 | Isp Investments Llc | Aqueous emulsion polymers as rheology modifiers, compositions thereof, and method of use |
JP6813586B2 (ja) | 2016-03-03 | 2021-01-13 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | エアゾールフケ防止組成物 |
WO2017165191A2 (en) | 2016-03-23 | 2017-09-28 | The Procter & Gamble Company | Imaging method for determining stray fibers |
US9717674B1 (en) | 2016-04-06 | 2017-08-01 | The Procter & Gamble Company | Skin cleansing compositions comprising biodegradable abrasive particles |
DE102016207877A1 (de) | 2016-05-09 | 2017-11-09 | Clariant International Ltd | Stabilisatoren für Silikatfarben |
JP6925168B2 (ja) * | 2016-05-31 | 2021-08-25 | ライオン株式会社 | 繊維製品用の液体洗浄剤組成物 |
US10159638B2 (en) | 2016-06-21 | 2018-12-25 | Johnson & Johnson Consumer Inc. | Personal care compositions containing complexing polyelectrolytes |
EP3272327A1 (de) * | 2016-07-19 | 2018-01-24 | Basf Se | Wässrige tensid-zusammensetzungen |
MX2019001827A (es) | 2016-08-19 | 2019-06-06 | Unilever Nv | Una composicion antimicrobiana. |
CN109640930B (zh) | 2016-08-19 | 2021-11-26 | 联合利华知识产权控股有限公司 | 抗微生物组合物 |
US10806692B2 (en) | 2016-10-03 | 2020-10-20 | The Procter & Gamble Company | Skin cleansing compositions comprising color stable abrasive particles |
US10888505B2 (en) | 2016-10-21 | 2021-01-12 | The Procter And Gamble Company | Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space |
MX2019003107A (es) | 2016-10-21 | 2019-09-13 | Procter & Gamble | Productos de champu compactos y estables con baja viscosidad y agente reductor de viscosidad. |
CN109715131B (zh) | 2016-10-21 | 2022-04-26 | 宝洁公司 | 低粘度毛发护理组合物 |
CN109843382A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型 |
CN109843258A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 表示毛发调理有益效果的浓缩型洗发剂泡沫剂型 |
US11141361B2 (en) | 2016-10-21 | 2021-10-12 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair volume benefits |
US10842720B2 (en) | 2016-10-21 | 2020-11-24 | The Procter And Gamble Company | Dosage of foam comprising an anionic/zwitterionic surfactant mixture |
WO2018075838A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
EP3315580A1 (en) | 2016-10-26 | 2018-05-02 | Covestro LLC | Antimicrobial proppant |
JP7328893B2 (ja) | 2016-12-19 | 2023-08-17 | ルブリゾル アドバンスド マテリアルズ, インコーポレイテッド | 界面活性剤応答性乳化重合マイクロゲル |
US20180185255A1 (en) | 2017-01-05 | 2018-07-05 | The Procter & Gamble Company | Method of Selecting Mild Skin Cleansers |
MX2019011450A (es) * | 2017-03-30 | 2019-11-01 | Unilever Nv | Composiciones antimicrobianas de limpieza personal. |
US11421048B2 (en) | 2017-05-04 | 2022-08-23 | Lubrizol Advanced Materials, Inc. | Dual activated microgel |
BR112019023383A2 (pt) | 2017-05-10 | 2020-06-16 | Unilever N.V. | Composição de detergente líquida aquosa para lavagem de tecidos e método doméstico de tratamento de um tecido |
US11312927B2 (en) | 2017-05-29 | 2022-04-26 | Dow Global Technologies Llc | Foaming hard surface cleaning composition with a pH color change |
US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
JP7063556B2 (ja) | 2017-07-04 | 2022-05-09 | ロレアル | 起泡性クレンザー |
JP7036547B2 (ja) * | 2017-07-14 | 2022-03-15 | 花王株式会社 | 毛髪洗浄剤組成物 |
US11517013B2 (en) | 2017-08-25 | 2022-12-06 | Vive Crop Protection Inc. | Multi-component, soil-applied, pesticidal compositions |
EP3688128B1 (en) * | 2017-09-28 | 2021-05-26 | Lubrizol Advanced Materials, Inc. | Polymeric thickener for iridescent liquid hand soap compositions |
WO2019074988A1 (en) | 2017-10-10 | 2019-04-18 | The Procter & Gamble Company | METHOD OF TREATING HAIR OR SKIN WITH PERSONAL FOAM COMPOSITION IN THE FORM OF FOAM |
WO2019074993A1 (en) | 2017-10-10 | 2019-04-18 | The Procter & Gamble Company | SULFATE FREE TRANSPARENT PERSONAL CLEANING COMPOSITION COMPRISING LOW INORGANIC SALT |
CN111278418A (zh) | 2017-10-10 | 2020-06-12 | 宝洁公司 | 具有基于氨基酸的阴离子表面活性剂和阳离子聚合物的致密型洗发剂组合物 |
JP6945746B2 (ja) | 2017-10-10 | 2021-10-06 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | サルフェートフリーの界面活性剤を含有するコンパクトなシャンプー組成物 |
EP3697377A1 (en) * | 2017-10-20 | 2020-08-26 | The Procter and Gamble Company | Compact aerosol hair care composition comprising hydrocarbon foaming agent |
WO2019079405A1 (en) | 2017-10-20 | 2019-04-25 | The Procter & Gamble Company | AEROSOL FOAMING CLEANSER FOR THE SKIN |
EP3697375B1 (en) | 2017-10-20 | 2021-12-01 | The Procter & Gamble Company | Aerosol foam skin cleanser |
JP2021501811A (ja) | 2017-11-06 | 2021-01-21 | ローム アンド ハース カンパニーRohm And Haas Company | 高炭素数の疎水性物質を有する疎水的に修飾されたアクリルレオロジー改質剤 |
TW201930532A (zh) | 2017-11-17 | 2019-08-01 | 荷蘭商安科智諾貝爾化學國際公司 | 鹼可膨脹的多功能流變修飾劑 |
US20190159987A1 (en) * | 2017-11-24 | 2019-05-30 | Amorepacific Corporation | Aqueous solution for solubilizing salicylic acid, a method for preparation thereof, and a cosmetic composition comprising the same |
KR102635195B1 (ko) * | 2017-11-24 | 2024-02-13 | (주)아모레퍼시픽 | 살리실산 가용화 수용액, 그 제조방법, 및 이를 포함하는 화장료 조성물 |
WO2019113035A1 (en) | 2017-12-08 | 2019-06-13 | The Procter & Gamble Company | Methods of screening for mild skin cleanser |
JP7280265B2 (ja) | 2017-12-20 | 2023-05-23 | ザ プロクター アンド ギャンブル カンパニー | シリコーンポリマーを含有する透明なシャンプー組成物 |
CN108187351A (zh) * | 2018-01-17 | 2018-06-22 | 厦门卡拉风娱乐有限公司 | 一种能形成稳定特大泡泡的泡泡液 |
WO2019236646A1 (en) | 2018-06-05 | 2019-12-12 | The Procter & Gamble Company | Clear cleansing composition |
JP2021528410A (ja) | 2018-06-29 | 2021-10-21 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 低界面活性剤エアゾール抗ふけ組成物 |
WO2020112486A1 (en) | 2018-11-29 | 2020-06-04 | The Procter & Gamble Company | Methods for screening personal care products |
EP3894015A1 (en) * | 2018-12-14 | 2021-10-20 | The Procter & Gamble Company | Shampoo composition comprising sheet-like microcapsules |
WO2020264052A1 (en) * | 2019-06-24 | 2020-12-30 | Hempvana, Llc | Compositions comprising cannabis sativa oil and uses thereof |
US11896689B2 (en) | 2019-06-28 | 2024-02-13 | The Procter & Gamble Company | Method of making a clear personal care comprising microcapsules |
WO2021016729A1 (en) * | 2019-07-26 | 2021-02-04 | L'oreal | Composition for cleansing and/or removing makeup from keratin materials |
CN114746153A (zh) * | 2019-12-06 | 2022-07-12 | 宝洁公司 | 具有增强头皮活性物质沉积的不含硫酸盐的组合物 |
WO2021122717A1 (en) | 2019-12-17 | 2021-06-24 | L'oreal | New henna-based extract for use in dyeing keratin fibers, its preparation method and compositions containing it |
CN114981016A (zh) | 2020-02-14 | 2022-08-30 | 宝洁公司 | 具有悬浮在其中的美学设计的适于储存液体组合物的瓶子 |
CN115151310A (zh) | 2020-02-27 | 2022-10-04 | 宝洁公司 | 功效和美观性增强的含硫去头皮屑组合物 |
BR112022023878A2 (pt) | 2020-06-02 | 2022-12-20 | Unilever Ip Holdings B V | Composição de limpeza pessoal, método para fornecer fator de proteção solar melhorado e uso da composição |
US11890263B2 (en) | 2020-08-13 | 2024-02-06 | Johnson & Johnson Consumer Inc. | Methods and compositions suitable for the treatment of acne |
MX2023005963A (es) | 2020-12-04 | 2023-06-07 | Procter & Gamble | Composiciones para el cuidado del cabello que comprenden materiales de reduccion del mal olor. |
US11633072B2 (en) | 2021-02-12 | 2023-04-25 | The Procter & Gamble Company | Multi-phase shampoo composition with an aesthetic design |
US20220378684A1 (en) | 2021-05-14 | 2022-12-01 | The Procter & Gamble Company | Shampoo Compositions Containing a Sulfate-Free Surfactant System and Sclerotium Gum Thickener |
US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
DE102022208941A1 (de) | 2022-08-29 | 2024-02-29 | Beiersdorf Aktiengesellschaft | Reinigungszubereitung zur Rasurvorbereitung und Gesichtsreinigung |
FR3140544A1 (fr) | 2022-10-10 | 2024-04-12 | L'oreal | Composition cosmetique capillaire detergente et exfoliante comprenant de l’acide salicylique et des particules en suspension |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US501376A (en) * | 1893-07-11 | Armature | ||
BE535125A (ko) * | 1954-01-25 | |||
IT580324A (ko) * | 1956-11-21 | |||
US3208911A (en) | 1962-06-13 | 1965-09-28 | Dow Corning | Process for treating hair with ionic oilin-water emulsions of polyorganosiloxanes |
US3964500A (en) | 1973-12-26 | 1976-06-22 | Lever Brothers Company | Lusterizing shampoo containing a polysiloxane and a hair-bodying agent |
US4152416A (en) | 1976-09-17 | 1979-05-01 | Marra Dorothea C | Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness |
US4110291A (en) | 1977-02-18 | 1978-08-29 | Gaf Corporation | Copolymer emulsions for thickening acrylic polymer latices |
US4138380A (en) | 1977-02-18 | 1979-02-06 | Gaf Corporation | Preparation of copolymer emulsions of an α,β-unsaturated carboxylic acid and methyl acrylate |
JPS55108411A (en) * | 1978-12-29 | 1980-08-20 | Rohm & Haas | Waterrinsoluble emulsion copolymer |
US4384974A (en) | 1979-07-27 | 1983-05-24 | Revlon, Inc. | Stable water-in-oil emulsions |
US4341799A (en) | 1980-12-29 | 1982-07-27 | Good Allen H | Lotion and method for cleansing and conditioning the skin therewith |
US4364837A (en) | 1981-09-08 | 1982-12-21 | Lever Brothers Company | Shampoo compositions comprising saccharides |
US4465619A (en) | 1981-11-13 | 1984-08-14 | Lever Brothers Company | Built liquid detergent compositions |
US4529773A (en) * | 1982-03-17 | 1985-07-16 | David Witiak | Alkali-soluble emulsion polymers in acidic surfactant compositions |
US4438096A (en) | 1982-05-27 | 1984-03-20 | Helene Curtis Industries, Inc. | Pearlescent shampoo |
DE3427220A1 (de) * | 1984-07-24 | 1986-01-30 | Cassella Ag, 6000 Frankfurt | Verfahren zur herstellung von copolymeren |
DE3445549A1 (de) * | 1984-12-14 | 1986-06-19 | Henkel KGaA, 4000 Düsseldorf | Acrylatdispersion und deren verwendung zur verdickung von wasserstoffperoxid-zubereitungen |
US4788006A (en) | 1985-01-25 | 1988-11-29 | The Procter & Gamble Company | Shampoo compositions containing nonvolatile silicone and xanthan gum |
US4654207A (en) | 1985-03-13 | 1987-03-31 | Helene Curtis Industries, Inc. | Pearlescent shampoo and method for preparation of same |
LU86309A1 (fr) * | 1986-02-14 | 1987-09-10 | Oreal | Composition pour fibres keratiniques et en particulier pour cheveux humains,a base de nitroanilines halogenes,procede de teinture utilisant ladite composition tinctoriale et nouvelles 2-nitroanilines halogenees utilisees |
US5019376A (en) | 1989-03-13 | 1991-05-28 | S. C. Johnson & Son, Inc. | Sparkling pearlescent personal care compositions |
US5230823A (en) | 1989-05-22 | 1993-07-27 | The Procter & Gamble Company | Light-duty liquid or gel dishwashing detergent composition containing an alkyl ethoxy carboxylate surfactant |
US5011681A (en) | 1989-10-11 | 1991-04-30 | Richardson-Vicks, Inc. | Facial cleansing compositions |
DE69002050T2 (de) * | 1989-12-08 | 1993-12-23 | Oreal | Reduzierende kosmetische Zusammensetzung für die Dauerwelle auf Basis von Cysteamin und/oder seinem N-Acetylderivat und einem kationischen Polymer sowie seine Verwendung in einem Verfahren zur Haardauerverformung. |
GB2245279B (en) | 1990-06-20 | 1993-04-07 | Unilever Plc | Shampoo composition |
JP2868292B2 (ja) * | 1990-06-29 | 1999-03-10 | マツダ株式会社 | 自動車のスペアタイヤ格納構造及び格納方法 |
JP2587535B2 (ja) | 1990-11-17 | 1997-03-05 | サンスター株式会社 | パール状シャンプー組成物 |
JP2543252B2 (ja) | 1990-11-17 | 1996-10-16 | サンスター株式会社 | パ―ル状シャンプ―組成物 |
FR2676923B1 (fr) | 1991-06-03 | 1995-04-21 | Oreal | Composition de traitement des matieres keratiniques a base de silicone et de latex. |
CA2098641A1 (en) * | 1992-06-30 | 1993-12-31 | Raymond J. Thimineur | Shampoo composition |
GB9320556D0 (en) | 1993-10-06 | 1993-11-24 | Unilever Plc | Hair conditioning composition |
US5456851A (en) * | 1994-04-07 | 1995-10-10 | Johnson & Johnson Consumer Products, Inc. | Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole |
US5534265A (en) | 1994-08-26 | 1996-07-09 | The Procter & Gamble Company | Thickened nonabrasive personal cleansing compositions |
US5656257A (en) | 1995-04-28 | 1997-08-12 | Electronics Hair Styling, Inc. | Shampoo and conditioning composition |
US6165454A (en) | 1997-09-18 | 2000-12-26 | Colgate-Palmolive Company | Stabilized hair care products |
US5968493A (en) | 1997-10-28 | 1999-10-19 | Amway Corportion | Hair care composition |
GB9804720D0 (en) * | 1998-03-05 | 1998-04-29 | Unilever Plc | Shampoo compositions |
GB9808310D0 (en) | 1998-04-20 | 1998-06-17 | Unilever Plc | Shampoo compositions |
US6533873B1 (en) | 1999-09-10 | 2003-03-18 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Suspending clear cleansing formulation |
US6635702B1 (en) * | 2000-04-11 | 2003-10-21 | Noveon Ip Holdings Corp. | Stable aqueous surfactant compositions |
-
2000
- 2000-04-11 US US09/547,595 patent/US6635702B1/en not_active Expired - Lifetime
-
2001
- 2001-04-11 BR BRPI0109990A patent/BRPI0109990B1/pt not_active IP Right Cessation
- 2001-04-11 KR KR1020097014814A patent/KR20090088964A/ko not_active Application Discontinuation
- 2001-04-11 RU RU2002130255/15A patent/RU2002130255A/ru not_active Application Discontinuation
- 2001-04-11 KR KR1020027013606A patent/KR100866186B1/ko active IP Right Grant
- 2001-04-11 CA CA002405222A patent/CA2405222C/en not_active Expired - Lifetime
- 2001-04-11 EP EP09168101A patent/EP2138561A1/en not_active Ceased
- 2001-04-11 AU AU5759201A patent/AU5759201A/xx active Pending
- 2001-04-11 CN CNB018079652A patent/CN100475178C/zh not_active Expired - Lifetime
- 2001-04-11 MX MXPA02009941A patent/MXPA02009941A/es active IP Right Grant
- 2001-04-11 EP EP01931125A patent/EP1272159B1/en not_active Revoked
- 2001-04-11 AT AT01931125T patent/ATE440130T1/de not_active IP Right Cessation
- 2001-04-11 JP JP2001574070A patent/JP5465820B2/ja not_active Expired - Lifetime
- 2001-04-11 KR KR1020087003835A patent/KR100947959B1/ko active IP Right Grant
- 2001-04-11 AU AU2001257592A patent/AU2001257592B2/en not_active Ceased
- 2001-04-11 DE DE60139613T patent/DE60139613D1/de not_active Expired - Lifetime
- 2001-04-11 WO PCT/US2001/040480 patent/WO2001076552A2/en active Application Filing
- 2001-04-11 ES ES01931125T patent/ES2329872T3/es not_active Expired - Lifetime
- 2001-04-11 CZ CZ20023712A patent/CZ20023712A3/cs unknown
-
2002
- 2002-10-09 ZA ZA200208119A patent/ZA200208119B/xx unknown
-
2003
- 2003-06-23 US US10/602,956 patent/US6897253B2/en not_active Expired - Lifetime
-
2005
- 2005-03-17 US US11/083,243 patent/US7217752B2/en not_active Expired - Lifetime
-
2013
- 2013-08-30 JP JP2013179640A patent/JP2014028957A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120125632A (ko) * | 2010-02-12 | 2012-11-16 | 로디아 오퍼레이션스 | 유동성 개질제 폴리머 |
KR20130115276A (ko) * | 2010-10-05 | 2013-10-21 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 아크릴레이트 공중합체 증점제 |
Also Published As
Publication number | Publication date |
---|---|
BR0109990A (pt) | 2004-03-23 |
CN1422147A (zh) | 2003-06-04 |
KR20030005275A (ko) | 2003-01-17 |
JP5465820B2 (ja) | 2014-04-09 |
EP1272159A2 (en) | 2003-01-08 |
US20050158268A1 (en) | 2005-07-21 |
JP2003530446A (ja) | 2003-10-14 |
WO2001076552A2 (en) | 2001-10-18 |
ZA200208119B (en) | 2003-07-17 |
DE60139613D1 (de) | 2009-10-01 |
KR20090088964A (ko) | 2009-08-20 |
CA2405222C (en) | 2008-04-08 |
RU2002130255A (ru) | 2004-03-27 |
US7217752B2 (en) | 2007-05-15 |
KR100866186B1 (ko) | 2008-10-30 |
CA2405222A1 (en) | 2001-10-18 |
CN100475178C (zh) | 2009-04-08 |
AU2001257592B2 (en) | 2006-02-23 |
ES2329872T3 (es) | 2009-12-02 |
AU5759201A (en) | 2001-10-23 |
MXPA02009941A (es) | 2003-02-12 |
US20040087668A1 (en) | 2004-05-06 |
US6897253B2 (en) | 2005-05-24 |
JP2014028957A (ja) | 2014-02-13 |
EP2138561A1 (en) | 2009-12-30 |
KR100947959B1 (ko) | 2010-03-15 |
EP1272159B1 (en) | 2009-08-19 |
BRPI0109990B1 (pt) | 2015-11-17 |
ATE440130T1 (de) | 2009-09-15 |
US6635702B1 (en) | 2003-10-21 |
WO2001076552A3 (en) | 2002-09-19 |
CZ20023712A3 (cs) | 2003-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100947959B1 (ko) | 안정한 수성 계면활성제 조성물 | |
AU2001257592A1 (en) | Stable aqueous surfactant compositions | |
JP5922755B2 (ja) | パーソナルケア組成物 | |
JP6000261B2 (ja) | アクリレートコポリマー増粘剤 | |
JP6087814B2 (ja) | 構造化アクリレートコポリマー増粘剤 | |
JP5991972B2 (ja) | アクリルコポリマー増粘剤のブレンド | |
US20050265936A1 (en) | Cleansing foaming sunscreen lotion | |
JP2014500236A (ja) | 多相系において使用するための構造化アクリレートコポリマー | |
EP1685827A1 (en) | Rheology modifier for aqueous systems | |
JPH07330538A (ja) | 濃厚化粧品組成物 | |
EP1602355A1 (en) | Cleansing foaming formulation | |
JP2004529903A (ja) | 化粧剤及び医薬剤 | |
CA2618882A1 (en) | Process for preparing stable aqueous surfactant compositions of a crosslinked alkali-swellable acrylate polymer | |
WO2012150259A1 (en) | Composition | |
JP2014513111A (ja) | 疎水的に修飾されたアニオン性ポリマーおよびメチルセルロースを含むヘアケア組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130226 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140225 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150226 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160224 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180228 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190227 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20200227 Year of fee payment: 11 |